Craniofacial-Deafness-Hand Syndrome

Mendelian MONDO:0007395 Pathograph 18 Show in embeddings browser multiple congenital anomalies/dysmorphic syndrome without intellectual disability hereditary disease Sensorineural Hearing Loss

Craniofacial-deafness-hand syndrome (CDHS) is an ultra-rare autosomal dominant multiple congenital anomaly syndrome caused by heterozygous missense variants in the paired domain of PAX3, the same neural-crest transcription factor whose loss-of-function alleles cause Waardenburg syndrome types 1 and 3. The cardinal triad is (1) a distinctive craniofacial gestalt — flat facial profile over a normal calvarium, hypertelorism, short downslanting palpebral fissures, a depressed nasal bridge with a button tip and slit-like nares, a small "pursed" mouth, and radiographically absent or hypoplastic nasal bones with a small maxilla; (2) profound sensorineural hearing loss; and (3) ulnar deviation of the hands with flexion contractures of the third through fifth digits and limited wrist movement. CDHS is allelic to, but clinically distinct from, Waardenburg syndrome: the founding family characteristically lacked the classic Waardenburg pigmentary stigmata (white forelock, heterochromia iridis), and the imaging findings — absent/hypoplastic nasal bones and a hypoplastic ulnar styloid over a normal calvarium — were considered the discriminating feature. The evidence base is exceptionally small: three affected individuals across two generations of one family carrying the PAX3 Asn47Lys allele, plus a handful of later single-case reports, giving a reported prevalence below 1 in 1,000,000.

Ask OpenScientist

Ask a research question about Craniofacial-Deafness-Hand Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Mappings
1
Inheritance
6
Pathophys.
19
Phenotypes
3
Gaps
18
Pathograph
1
Genes
3
Variants
5
Medical Actions
2
Differentials
1
Models
6
References
2
Deep Research
🔗

Mappings

MONDO
MONDO:0007395 craniofacial-deafness-hand syndrome
skos:exactMatch MONDO
👪

Inheritance

1
Autosomal dominant HP:0000006
CDHS segregates as an autosomal dominant trait. In the founding family the phenotype was transmitted from an affected mother to two of her children, giving three affected individuals across two generations. The two later molecularly characterized patients (a PAX3 p.Thr31Pro missense variant and a de novo 2q36.1 deletion encompassing PAX3) were simplex cases with unaffected parents, so both inherited and de novo dominant mechanisms are documented.
autosomal dominant inheritance
Show evidence (2 references)
PMID:8664898 SUPPORT Human Clinical
"Craniofacial-deafness-hand syndrome (MIM 122880) is inherited as an autosomal dominant mutation"
States the autosomal dominant mode of inheritance for CDHS directly.
PMID:14556253 SUPPORT Human Clinical
"Because of three affected family members in two generations and a phenotype of midfacial anomalies and dystopia canthorum resembling Waardenburg syndrome, a search for mutations in the PAX3 gene was undertaken."
Documents vertical transmission across two generations in the founding family, consistent with dominant inheritance.
?

Discussions and Knowledge Gaps

3
Does murine Pax3 loss of function model the CDHS craniofacial phenotype, given that the splotch mouse is dominated by neural tube closure defects while the human paired-domain missense phenotype is dominated by midfacial skeletal hypoplasia with no reported neural tube defect?
HUMAN MODEL MISMATCH OPEN cdhs_pax3_null_vs_missense_model_fidelity
Attached to
pathophysiology#Cranial Neural Crest Patterning Failure pathophysiology#Craniofacial Skeletal Hypoplasia
Every mechanistic claim about CDHS craniofacial development is extrapolated from Pax3 loss-of-function models, but the direction of the mismatch is substantive rather than cosmetic. The murine models are null or severely-hypomorphic alleles whose signature phenotype is exencephaly and spina bifida; the human CDHS alleles are paired-domain missense substitutions that the founding report proposed to be MORE damaging than the loss-of-function alleles causing Waardenburg syndrome type 1, and CDHS patients have not been reported with neural tube defects. A null-allele model therefore cannot test the allele-class hypothesis that defines CDHS, and its craniofacial readout cannot be assumed to correspond to the human midfacial phenotype. The cochlear melanocyte arm of the mechanism is on firmer ground because the murine phenotype (loss of stria vascularis intermediate cells) maps directly onto the shared human feature of sensorineural hearing loss.
Proposed experiments
Pax3 N47K knock-in versus null allele phenotype comparison
exp_cdhs_pax3_n47k_knockin_vs_null
Generate a knock-in mouse carrying the orthologous Pax3 N47K substitution and compare its craniofacial, otic and limb phenotypes against a Pax3 null allele on the same genetic background, to test directly whether the CDHS allele class acts by a mechanism distinct from haploinsufficiency.
Comparative DNA-binding and transactivation assay of CDHS versus Waardenburg alleles
exp_cdhs_pax3_allele_biochemistry
Assay DNA binding, target-gene occupancy and transactivation of PAX3 N47K and T31P against wild-type protein and against the Waardenburg-associated N47H protein, to determine whether the CDHS alleles are hypomorphic, dominant-negative or neomorphic.
Show evidence (2 references)
PMID:8421686 SUPPORT Model Organism
"The splotch (Sp) mouse mutant displays defects in neural tube closure in the form of exencephaly and spina bifida."
Establishes that the murine model's signature phenotype is a neural tube closure defect, which is not a reported feature of human CDHS — the observation that motivates this mismatch.
PMID:8664898 SUPPORT Human Clinical
"appears to have a more drastic effect on the phenotype than missense, frameshift and deletion mutations of PAX3 that cause Waardenburg syndrome type 1"
States the allele-class hypothesis that a loss-of-function model cannot test, since the CDHS allele is proposed to act differently from the loss-of-function alleles the murine models carry.
By what mechanism does a PAX3 paired-domain missense allele produce the hand phenotype of CDHS — and specifically, does the somitic/limb-muscle route account for the skeletal findings (hypoplastic ulnar styloid) as well as the contractural ones (ulnar deviation, digit flexion contractures)?
KNOWLEDGE GAP OPEN cdhs_hand_phenotype_mechanism_unexplained
Attached to
pathophysiology#Somitic and Limb Musculoskeletal Patterning Disturbance pathophysiology#Altered Paired-Domain DNA Recognition
The hand is one third of the cardinal triad and carries three diagnostic phenotypes, yet it is the least mechanistically supported arm of the entry. Two things are worth separating. First, the lineage question is settled enough to model: the wrist and limb musculature are somite and lateral-plate derivatives, so they cannot descend from the cranial neural crest node, and PAX3's dermomyotome/limb-muscle role supplies a plausible separate branch — which is why the Somitic and Limb Musculoskeletal Patterning Disturbance node exists at HYPOTHETICAL confidence. Second, and still open: that myogenic route is a natural explanation for deviation and contracture, but not for hypoplasia of a bone. The hypoplastic ulnar styloid therefore has no incoming causal edge in this entry, deliberately, rather than being attached to a node that does not explain it. No limb or muscle tissue from a CDHS patient has ever been examined, and no murine model carries a CDHS allele, so both halves of the question are open on human evidence.
Proposed experiments
Systematic upper-limb imaging and muscle phenotyping in ascertained CDHS patients
exp_cdhs_limb_imaging_and_muscle_phenotyping
Combine hand/wrist radiography with MRI or ultrasound of the forearm and intrinsic hand musculature in any ascertained CDHS patient, to establish whether the deformity is primarily myogenic (muscle hypoplasia or imbalance with secondary joint deformity) or primarily skeletal (a dysplastic ulnar styloid and carpus), which the plain radiographs reported to date cannot distinguish.
Limb phenotyping of a Pax3 N47K knock-in allele
exp_cdhs_limb_phenotype_in_n47k_knockin
Phenotype forelimb musculature and the distal skeleton in the Pax3 N47K knock-in proposed under the model-fidelity discussion, comparing against a Pax3 null allele, to test whether the CDHS allele class produces the human-like deviation-and-contracture pattern rather than the absent-muscle pattern of the null.
Show evidence (1 reference)
PMID:7744814 SUPPORT Model Organism
"Mutations in Pax-3 account for the mouse mutant Splotch which develops without limb musculature."
The strongest available support for a PAX3-dependent limb mechanism, and simultaneously the measure of the gap: it is a murine null allele producing absent musculature, not a human missense allele producing deviation, contracture and a hypoplastic styloid process.
Is the cardiovascular involvement reported in one CDHS patient (patent ductus arteriosus with secondary pulmonary hypertension) a genuine part of the CDHS phenotypic spectrum, or a coincidental finding in a single patient?
KNOWLEDGE GAP OPEN cdhs_cardiovascular_association_single_case
Attached to
pathophysiology#Cranial Neural Crest Patterning Failure
The association rests on one 21-year-old patient with a novel PAX3 p.Thr31Pro variant. The argument for causality is reasonable — more than 100 congenital-heart-disease genes were screened without an alternative explanation, and PAX3 is expressed in cardiac neural crest, whose derivatives build the outflow tract — but it remains a single unreplicated case, and no cardiac assessment was reported for the founding family. Resolving this matters practically, because it determines whether echocardiography belongs in the baseline evaluation of every newly diagnosed patient.
Proposed experiments
Systematic echocardiographic screening of ascertained CDHS patients
exp_cdhs_systematic_echocardiography
Perform echocardiography on surviving members of the founding N47K family and on any newly ascertained CDHS patient, and report the result whether positive or negative, so that the denominator for the cardiovascular association becomes interpretable.
Show evidence (2 references)
PMID:39850491 SUPPORT Human Clinical
"The genetic findings provided a definitive diagnosis of Craniofacial-Deafness-Hand Syndrome, an extremely rare autosomal dominant condition, but found no variants that explain the patient's cardiac phenotype."
The sole source of the cardiovascular association. Marked PARTIAL because it establishes only that no alternative genetic explanation was found in one patient, which is suggestive rather than confirmatory.
PMID:15226254 SUPPORT INDIRECT Model Organism
"Embryos homozygous for the Sp2H mutation show delayed onset of cardiac neural crest emigration"
Supplies the biological plausibility for the association: murine Pax3 loss perturbs cardiac neural crest, whose derivatives build the outflow tract. INDIRECT because a mouse null allele cannot establish that a human CDHS missense allele causes patent ductus arteriosus.
⚙

Pathophysiology

6
PAX3 Paired-Domain Missense Variant
CDHS is caused by heterozygous missense substitution within the paired domain, the N-terminal sequence-specific DNA-binding module of the PAX3 transcription factor. The founding family carries Asn47Lys (N47K) in exon 2; a second, unrelated patient carries p.Thr31Pro (c.A91C) in the same domain. The identity of the substitution matters: a different substitution at the very same codon, Asn47His, causes Waardenburg syndrome type 3 rather than CDHS, so CDHS is defined by an allele class rather than simply by PAX3 dysfunction.
PAX3 hgnc:8617 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves PAX3 (hgnc:8617). hgnc:8617 is a gene from the HUGO Gene Nomenclature Committee.
sequence-specific DNA binding GO:0043565 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves decreased sequence-specific DNA binding (GO:0043565). GO:0043565 is a molecular function from the Gene Ontology. ↓ DECREASED
Downstream
Altered Paired-Domain DNA Recognition
Show evidence (3 references)
PMID:8664898 SUPPORT Human Clinical
"In a family of three affected individuals with this syndrome, a mother and two children, a missense mutation (Asn47Lys) in the paired domain of PAX3 was initially detected by SSCP analysis."
Identifies the causal paired-domain missense allele in the founding CDHS family.
PMID:8664898 SUPPORT Human Clinical
"A previously described missense mutation in this same codon (Asn47His) is associated with Waardenburg syndrome type 3 (Hoth et al., 1993)."
Establishes that the specific amino-acid substitution at codon 47, not merely the affected codon, determines whether the phenotype is CDHS or Waardenburg syndrome type 3.
PMID:39850491 SUPPORT Human Clinical
"The patient's variant is found within the conserved paired box domain (PB)"
Confirms that the second reported CDHS allele also lies in the paired domain, supporting a domain-restricted allele class.
Altered Paired-Domain DNA Recognition
The paired domain comprises two helix-turn-helix subdomains whose C-terminal recognition helices make base-specific contacts in the DNA major groove. Substitution of a basic residue for the asparagine at position 47 — a residue conserved across all known murine Pax and human PAX genes — perturbs this base-specific readout. The resulting change in PAX3 transcriptional output is proposed to be more damaging than the haploinsufficiency produced by the missense, frameshift and deletion alleles that cause Waardenburg syndrome type 1, which is the mechanistic rationale for the distinct CDHS phenotype.
DNA-binding transcription factor activity GO:0003700 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves abnormal DNA-binding transcription factor activity (GO:0003700). GO:0003700 is a molecular function from the Gene Ontology. ⚠ ABNORMAL
Downstream
Cranial Neural Crest Patterning Failure
Somitic and Limb Musculoskeletal Patterning Disturbance
Show evidence (2 references)
PMID:8664898 SUPPORT Human Clinical
"Substitution of a basic amino acid for asparagine at residue 47, conserved in all known murine Pax and human PAX genes, appears to have a more drastic effect on the phenotype than missense, frameshift and deletion mutations of PAX3 that cause Waardenburg syndrome type 1."
States the proposed allele-severity model linking the specific paired-domain substitution to the more severe CDHS phenotype.
PMID:20643146 SUPPORT In Vitro
"At the structural level, this reflected an unexpected dependence on base-specific contacts in the PD"
Cell-based structure-function work showing that paired-domain function depends on base-specific DNA contacts, the class of interaction disrupted by the CDHS residue-47 substitution. Indirect: the specific CDHS alleles were not assayed, so this supports the general mechanism rather than the CDHS variant itself.
Cranial Neural Crest Patterning Failure
PAX3 specifies dorsal neural tube progenitors and is required for the induction, survival, migration and differentiation of neural crest cells. Disrupted PAX3 transcriptional output during the narrow embryonic window of neural crest patterning is the proposed common origin of the CDHS triad: the craniofacial skeleton, the melanocytic component of the inner ear, and — in the one reported case with cardiac involvement — the cardiac outflow tract are all neural-crest derivatives. This node is inferred from PAX3 developmental biology and model-organism data rather than from tissue studies of CDHS patients.
migratory cranial neural crest cell CL:0000008 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves migratory cranial neural crest cell (CL:0000008). CL:0000008 is a cell type from the Cell Ontology.
neural crest cell development GO:0014032 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal neural crest cell development (GO:0014032). GO:0014032 is a biological process from the Gene Ontology. ⚠ ABNORMAL neural crest cell migration GO:0001755 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal neural crest cell migration (GO:0001755). GO:0001755 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Downstream
Craniofacial Skeletal Hypoplasia
Cochlear Melanocyte Deficiency
Show evidence (3 references)
PMID:39850491 SUPPORT Human Clinical
"During development, this protein is expressed in skeletal muscle, the central nervous system, and neural crest"
Establishes PAX3 expression in neural crest derivatives as the developmental context for the CDHS phenotype.
PMID:26410165 SUPPORT Other
"highlighted the role of PAX3 and PAX7 in neural crest induction"
Supports the induction limb of this node's claim, which the expression-only quote above does not cover. Review article, hence OTHER.
PMID:29730428 SUPPORT Other
"Germline mutations of the murine Pax3 and human PAX3 genes cause deficiencies in these developmental lineages"
Supports the requirement claim rather than mere expression: germline PAX3 lesions produce deficiencies in the neural crest and skeletal muscle lineages named in the preceding sentence of the same abstract.
Craniofacial Skeletal Hypoplasia
Failure of neural-crest-derived membranous bone formation in the midface produces the radiographic hallmark of CDHS — absent or hypoplastic nasal bones with a small maxilla over a normal calvarium. The soft-tissue gestalt (flat facial profile, depressed nasal bridge with button tip and slit-like nares, small pursed mouth) follows from the underlying skeletal deficiency.
embryonic cranial skeleton morphogenesis GO:0048701 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal embryonic cranial skeleton morphogenesis (GO:0048701). GO:0048701 is a biological process from the Gene Ontology. ⚠ ABNORMAL
nasal bone UBERON:0001681 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in nasal bone (UBERON:0001681). UBERON:0001681 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (1 reference)
PMID:6859126 SUPPORT Human Clinical
"Common radiographic manifestations include small maxilla, absent or small nasal bones, and ulnar deviation of the hands."
The original description documents the midfacial skeletal hypoplasia that defines this node.
Somitic and Limb Musculoskeletal Patterning Disturbance
The hand arm of the CDHS triad cannot derive from the cranial neural crest node: the wrist skeleton and limb musculature are somite and lateral-plate derivatives, not cranial neural crest. PAX3 has a separate, well-established role in this second lineage — it is expressed in the lateral dermomyotome that gives rise to limb muscle progenitors, and murine Pax3 loss produces limbs without musculature. The same upper-limb musculoskeletal involvement separates Waardenburg syndrome type 3 from type 1, so a shared PAX3-dependent limb mechanism is the natural reading of the CDHS hand phenotype. This node is HYPOTHETICAL and deliberately broad. No study has examined limb or muscle tissue from a CDHS patient, and the myogenic route does not by itself account for the skeletal element of the phenotype (the hypoplastic ulnar styloid), which is why the accompanying knowledge-gap discussion keeps that specific question open rather than treating this node as settled.
skeletal muscle tissue development GO:0007519 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal skeletal muscle tissue development (GO:0007519). GO:0007519 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Downstream
Ulnar Deviation of the Hand
Flexion Contractures of the Fingers
Limited Wrist Movement
Show evidence (3 references)
PMID:7744814 SUPPORT Model Organism
"Pax3 is an evolutionarily conserved transcription factor expressed in the lateral dermomyotome, a region that gives rise to limb muscle progenitors."
Establishes the somitic/limb lineage in which PAX3 acts, distinct from the cranial neural crest lineage of the sibling node. PARTIAL because it is murine and general PAX3 biology, not CDHS-specific.
PMID:7744814 SUPPORT Model Organism
"Mutations in Pax-3 account for the mouse mutant Splotch which develops without limb musculature."
Demonstrates that Pax3 loss produces a limb phenotype in vivo, supplying the mechanistic plausibility for this node. PARTIAL: a murine null allele, not the human CDHS missense allele class.
PMID:29730428 SUPPORT Other
"This protein is expressed during development of skeletal muscle, central nervous system and neural crest derivatives, and regulates expression of target genes that impact on proliferation, survival, differentiation and motility in these lineages."
Names skeletal muscle as a PAX3-dependent lineage alongside neural crest, which is the basis for modelling the hand arm as a separate branch rather than as a downstream consequence of the cranial neural crest node.
Cochlear Melanocyte Deficiency
Cochlear melanocytes are the intermediate cells of the stria vascularis and generate the endocochlear potential on which mechanotransduction depends. They derive from neural crest, and in the mouse they arise from Pax3-traced melanoblasts and Plp1-traced Schwann cell precursors. Loss of Pax3 in the mouse significantly diminishes these cells, providing the leading mechanism for the profound sensorineural hearing loss shared by CDHS and the other PAX3-related disorders. This node rests on model-organism evidence; the cochlea has not been examined in a CDHS patient.
cochlear melanocyte (stria vascularis intermediate cell) CL:0000148 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cochlear melanocyte (stria vascularis intermediate cell), annotated with melanocyte (CL:0000148). CL:0000148 is a cell type from the Cell Ontology.
inner ear morphogenesis GO:0042472 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal inner ear morphogenesis (GO:0042472). GO:0042472 is a biological process from the Gene Ontology. ⚠ ABNORMAL
internal ear UBERON:0001846 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in internal ear (UBERON:0001846). UBERON:0001846 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Profound Sensorineural Hearing Loss
Show evidence (3 references)
PMID:38278860 SUPPORT Model Organism
"Lineage tracing and in situ hybridization show that Pax3+ derivatives contribute to S100+, Kir4.1+ and Dct+ melanocytes (intermediate cells) in the developing stria vascularis, all of which are significantly diminished in Pax3 mutant animals."
Mouse lineage-tracing evidence that Pax3 is required for cochlear melanocyte development, the proposed basis of the hearing loss.
PMID:38278860 SUPPORT Model Organism
"Cochlear melanocytes are intermediate cells in the stria vascularis that generate endocochlear potentials required for auditory function."
Explains why depletion of this cell population causes sensorineural hearing loss.
PMID:24565836 SUPPORT Model Organism
"suggesting that Pax3 lineage with a melanogenic fate migrated to the inner ear, yet failed to differentiate and survive without Pax3 function"
Independent murine fate-mapping evidence narrowing the defect to the melanogenic lineage: Pax3-lineage cells reach the inner ear but do not differentiate or survive, which is more specific than a general migration failure.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Craniofacial-Deafness-Hand Syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

19
Cardiovascular 2
Patent Ductus Arteriosus VERY_RARE HP:0001643 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Patent ductus arteriosus (HP:0001643). HP:0001643 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39850491 SUPPORT Human Clinical
"Craniofacial-Deafness-Hand Syndrome associated with a PAX3 variation and PDA, highlighting the gene"
Documents PDA in a molecularly confirmed CDHS patient. The full sentence in the source states this is the first such report, which is the basis for the VERY_RARE band and for treating the association as emerging.
Pulmonary Arterial Hypertension VERY_RARE HP:0002092 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Pulmonary arterial hypertension (HP:0002092). HP:0002092 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39850491 SUPPORT Human Clinical
"the echocardiogram demonstrated evidence of PDA, severe pulmonary hypertension, and valvular insuf"
Documents the pulmonary hypertension and its echocardiographic basis.
Ear 1
Profound Sensorineural Hearing Loss VERY_FREQUENT Profound sensorineural hearing impairment HP:0011476 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Profound sensorineural hearing impairment (HP:0011476). HP:0011476 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:8664898 SUPPORT Human Clinical
"profound sensorineural deafness"
Names profound sensorineural deafness as a defining CDHS feature.
PMID:14556253 SUPPORT Human Clinical
"Profound sensorineural hearing loss and ulnar deviation of the hands with flexion contractures of digits three, four and five was evident."
Confirms profound sensorineural hearing loss on 20-year follow-up of the founding family; the basis for the VERY_FREQUENT band, since it was present in all affected members.
Eye 1
Hypertelorism VERY_FREQUENT HP:0000316 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypertelorism (HP:0000316). HP:0000316 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:6859126 SUPPORT Human Clinical
"Both mother and child have a flat facial profile, hypertelorism, hypoplastic nose with slit-like nares, and a sensorineural hearing loss."
Documents hypertelorism in both originally described individuals.
Head and Neck 5
Flat Facial Profile VERY_FREQUENT Flat face HP:0012368 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Flat face (HP:0012368). HP:0012368 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:14556253 SUPPORT Human Clinical
"The syndrome consisted of a normal calvarium with a flat facial profile"
States the flat facial profile with normal calvarium as a core feature.
Downslanted Palpebral Fissures HP:0000494 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Downslanted palpebral fissures (HP:0000494). HP:0000494 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:14556253 SUPPORT Human Clinical
"hypertelorism and small palpebral fissures with an antimongoloid slant"
"Antimongoloid slant" is the older clinical term for downslanted palpebral fissures.
Depressed Nasal Bridge VERY_FREQUENT HP:0005280 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Depressed nasal bridge (HP:0005280). HP:0005280 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:14556253 SUPPORT Human Clinical
"a depressed nasal bridge with a button tip and slitlike nares"
Documents the depressed nasal bridge as a core craniofacial feature.
Short Nose HP:0003196 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Short nose (HP:0003196). HP:0003196 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:8664898 SUPPORT Human Clinical
"a small and short nose with slitlike nares"
Documents the short nose in CDHS.
Narrow Mouth HP:0000160 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Narrow mouth (HP:0000160). HP:0000160 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:14556253 SUPPORT Human Clinical
"a small "pursed" mouth"
Documents the small pursed mouth of CDHS.
Limbs 2
Flexion Contractures of the Fingers VERY_FREQUENT Flexion contracture of finger HP:0012785 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Flexion contracture of finger (HP:0012785). HP:0012785 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:14556253 SUPPORT Human Clinical
"flexion contractures of digits three, four and five"
Documents the digit-specific flexion contractures of CDHS.
Limited Wrist Movement HP:0006248 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Limited wrist movement (HP:0006248). HP:0006248 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:8664898 SUPPORT Human Clinical
"limited movement at the wrist and ulnar deviations of the fingers"
Documents limited wrist movement as a defining CDHS feature.
Other 8
Absent or Hypoplastic Nasal Bones VERY_FREQUENT Aplasia/Hypoplasia of the nasal bone HP:0010940 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Aplasia/Hypoplasia of the nasal bone (HP:0010940). HP:0010940 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:8664898 SUPPORT Human Clinical
"characterized by the absence or hypoplasia of the nasal bones"
Names absent/hypoplastic nasal bones as a defining feature of CDHS.
PMID:18553554 SUPPORT Human Clinical
"unique imaging findings of absence or hypoplasia of the nasal bones and a hypoplastic ulnar styloid"
Independent review of the founding family's imaging phenotype, and the basis for the frequency assignment (present in all affected individuals of the only well-characterized family).
Hypoplasia of the Maxilla HP:0000327 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypoplasia of the maxilla (HP:0000327). HP:0000327 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:6859126 SUPPORT Human Clinical
"Common radiographic manifestations include small maxilla"
Documents maxillary hypoplasia in the original description.
Short Palpebral Fissures HP:0012745 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Short palpebral fissure (HP:0012745). HP:0012745 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:8664898 SUPPORT Human Clinical
"hypertelorism, short palpebral fissures"
Names short palpebral fissures among the defining CDHS features.
Narrow Nares VERY_FREQUENT Narrow naris HP:0009933 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Narrow naris (HP:0009933). HP:0009933 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:8664898 SUPPORT Human Clinical
"a small and short nose with slitlike nares"
Documents the slit-like nares of the hypoplastic CDHS nose.
Dystopia Canthorum Telecanthus HP:0000506 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dystopia canthorum, annotated with Telecanthus (HP:0000506). HP:0000506 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:14556253 SUPPORT Human Clinical
"a phenotype of midfacial anomalies and dystopia canthorum resembling Waardenburg syndrome"
Documents dystopia canthorum in the CDHS family, and the reasoning that led to PAX3 testing.
Ulnar Deviation of the Hand VERY_FREQUENT HP:0009487 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Ulnar deviation of the hand (HP:0009487). HP:0009487 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:6859126 SUPPORT Human Clinical
"Common radiographic manifestations include small maxilla, absent or small nasal bones, and ulnar deviation of the hands."
Documents ulnar deviation of the hands in the original description.
PMID:14556253 SUPPORT Human Clinical
"ulnar deviation of the hands with flexion contractures of digits three, four and five was evident"
Confirms ulnar deviation across the founding family on long-term follow-up.
Hypoplastic Ulnar Styloid Process Abnormal ulnar styloid process morphology HP:0004035 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormal ulnar styloid process morphology (HP:0004035). HP:0004035 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:18553554 SUPPORT Human Clinical
"unique imaging findings of absence or hypoplasia of the nasal bones and a hypoplastic ulnar styloid"
Documents the hypoplastic ulnar styloid as part of the distinguishing CDHS imaging phenotype.
Clinodactyly of the 5th Finger OCCASIONAL HP:0004209 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Clinodactyly of the 5th finger (HP:0004209). HP:0004209 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39850491 SUPPORT Human Clinical
"as well as shortening and clinodactyly of the"
Documents fifth-finger clinodactyly in the p.Thr31Pro patient. Frequency is set to OCCASIONAL because it is reported in one of the small number of published patients and was not part of the founding family's description.
🧬

Genetic Associations

1
PAX3
Gene: PAX3 hgnc:8617 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is PAX3 (hgnc:8617). hgnc:8617 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
Show evidence (2 references)
PMID:8664898 SUPPORT Human Clinical
"PCR amplification using an oligonucleotide with a terminal 3'-residue match for the C-to-G transversion in codon 47 showed the presence of this mutation in the DNA from all affected members."
Demonstrates cosegregation of the PAX3 codon-47 variant with the CDHS phenotype in the founding family.
PMID:18553554 SUPPORT Human Clinical
"CDHS is also an allelic variant, and may be caused by PAX3 mutations affecting the paired box domain"
Independent statement that CDHS is a PAX3 paired-domain allelic disorder.
🔬

Variants

3
PAX3 p.Asn47Lys (N47K) Pathogenic
Gene: PAX3 hgnc:8617 HUGO Gene Nomenclature Committee (hgnc) Relation: this variant is in this gene This variant is in PAX3 (hgnc:8617). hgnc:8617 is a gene from the HUGO Gene Nomenclature Committee. missense
The founding CDHS allele, a missense substitution in the paired domain encoded by exon 2, arising from a C-to-G transversion in codon 47. It cosegregated with the phenotype in all three affected members of the reported family and was absent from unaffected members. Its clinical significance is anchored by the contrast with Asn47His at the same codon, which causes Waardenburg syndrome type 3.
Show evidence (2 references)
PMID:8664898 SUPPORT Human Clinical
"a missense mutation (Asn47Lys) in the paired domain of PAX3 was initially detected by SSCP analysis"
Identifies the variant and its domain location.
PMID:8664898 SUPPORT Human Clinical
"The DNA from unaffected members were refractory to PCR amplification with the mutation-specific oligonucleotide but did amplify a control primer pair in the same PCR reaction tube."
Establishes absence of the variant in unaffected relatives, supporting pathogenicity.
PAX3 c.91A>C p.Thr31Pro (T31P) Pathogenic
Gene: PAX3 hgnc:8617 HUGO Gene Nomenclature Committee (hgnc) Relation: this variant is in this gene This variant is in PAX3 (hgnc:8617). hgnc:8617 is a gene from the HUGO Gene Nomenclature Committee. missense
A novel de novo paired-domain missense variant identified by whole-exome sequencing in a 21-year-old Ecuadorian male, the second molecularly defined CDHS allele. It was absent from population databases, uniformly predicted damaging by in-silico tools, affects a residue conserved to zebrafish, and was classified pathogenic under ACMG criteria. The source publication contains an internal inconsistency in its variant prose, describing the substitution as "threonine-to-methionine" while giving p.T31P (proline) in the same sentence and throughout the rest of the paper; the protein change p.Thr31Pro is the one used consistently elsewhere in the report and is adopted here.
Show evidence (2 references)
PMID:39850491 SUPPORT Human Clinical
"We identified a novel pathogenic missense variant in the PAX3 gene (c.A91C,"
Reports the variant and its pathogenic classification.
PMID:39850491 SUPPORT Computational
"Conservation analysis showed the threonine residue is highly conserved across species, including zebra"
Conservation analysis supporting the pathogenicity classification. Tagged COMPUTATIONAL because this specific claim rests on sequence analysis rather than an experimental assay.
2q36.1 deletion encompassing PAX3 Pathogenic
Gene: PAX3 hgnc:8617 HUGO Gene Nomenclature Committee (hgnc) Relation: this variant is in this gene This variant is in PAX3 (hgnc:8617). hgnc:8617 is a gene from the HUGO Gene Nomenclature Committee. deletion
An approximately 862 kb de novo deletion at 2q36.1 including PAX3 was found by microarray in a 16-year-old girl with hearing loss who lacked the major features of Waardenburg syndrome type 1 but whose phenotype overlapped CDHS. This is a whole-gene dosage lesion rather than a paired-domain missense allele, so it does not fit the allele-class model proposed for CDHS; the case is curated here as phenotypic overlap and a caution against treating the genotype-phenotype correlation as absolute, not as a confirmed third CDHS allele.
Show evidence (2 references)
PMID:24839464 SUPPORT Human Clinical
"We report a 16 year old female presenting hearing loss and normal intellectual development, without major features of Waardenburg syndrome type 1, and without family history of the syndrome. Her phenotype, however, overlaps with features of craniofacial-deafness-hand syndrome."
Documents a PAX3-deletion patient whose phenotype overlaps CDHS. Marked PARTIAL because the authors describe phenotypic overlap rather than asserting a CDHS diagnosis.
PMID:24839464 SUPPORT Human Clinical
"Microarray analysis showed ~862 kb de novo deletion at 2q36.1 including PAX3."
Establishes the size, location and de novo origin of the deletion.
💊

Medical Actions

5
Hearing Rehabilitation
Action: RehabilitationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Rehabilitation (NCIT:C15315). NCIT:C15315 is a clinical intervention from the NCI Thesaurus. NCIT:C15315
Management of the profound congenital sensorineural hearing loss with amplification or cochlear implantation and accompanying speech-language habilitation. No CDHS-specific outcome data exist; this reflects the standard of care for congenital severe-to-profound sensorineural hearing loss and for the PAX3-related disorders generally.
Target Phenotypes: Profound sensorineural hearing impairment HP:0011476 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Profound sensorineural hearing impairment (HP:0011476). HP:0011476 is a phenotype from the Human Phenotype Ontology.
Hand Therapy and Orthopedic Management
Action: Occupational TherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Occupational Therapy (NCIT:C121351). NCIT:C121351 is a clinical intervention from the NCI Thesaurus. NCIT:C121351
Occupational and physical therapy for the digit flexion contractures and limited wrist movement, with surgical release considered case by case. As with hearing rehabilitation, no CDHS-specific outcome data exist; this is the standard of care for congenital hand contractures and is included so the third arm of the cardinal triad is not the only one without a management entry.
Target Phenotypes: Flexion contracture of finger HP:0012785 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Flexion contracture of finger (HP:0012785). HP:0012785 is a phenotype from the Human Phenotype Ontology. Limited wrist movement HP:0006248 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Limited wrist movement (HP:0006248). HP:0006248 is a phenotype from the Human Phenotype Ontology.
Symptomatic Pharmacotherapy for Pulmonary Hypertension
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: furosemide CHEBI:47426 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses furosemide (CHEBI:47426). CHEBI:47426 is a therapeutic agent from Chemical Entities of Biological Interest. bosentan CHEBI:51450 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses bosentan (CHEBI:51450). CHEBI:51450 is a therapeutic agent from Chemical Entities of Biological Interest. enalapril CHEBI:4784 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses enalapril (CHEBI:4784). CHEBI:4784 is a therapeutic agent from Chemical Entities of Biological Interest. sildenafil CHEBI:9139 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses sildenafil (CHEBI:9139). CHEBI:9139 is a therapeutic agent from Chemical Entities of Biological Interest.
In the single reported CDHS patient with an unrepaired patent ductus arteriosus and established severe pulmonary hypertension, surgical closure was judged non-viable and management was purely symptomatic: furosemide, bosentan, enalapril and sildenafil. The treating team was explicit that this regimen was palliative rather than curative, and framed the outcome as a consequence of diagnostic delay rather than an inevitable disease course.
Target Phenotypes: Pulmonary arterial hypertension HP:0002092 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Pulmonary arterial hypertension (HP:0002092). HP:0002092 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:39850491 SUPPORT Human Clinical
"symptomatic treatment was prescribed, which included a loop diuretic (furosemide), a dual endothelin receptor antagonist"
Documents the specific agents used for the cardiopulmonary complication.
PMID:39850491 SUPPORT Human Clinical
"These medications aim to manage symptoms rather than provide curative treatment"
States explicitly that the regimen is palliative, not disease-modifying.
Genetic Counseling
Action: Genetic CounselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Genetic Counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. NCIT:C15240
Autosomal dominant inheritance carries a 50% transmission risk to the offspring of an affected individual, as realized in the founding family where an affected mother had two affected children. Identification of the familial PAX3 variant enables predictive and reproductive testing.
Show evidence (1 reference)
PMID:14556253 SUPPORT Human Clinical
"The family had another child, a son, two years after the birth of the index case that had the exact manifestations as his mother and sister."
Documents recurrence in a second child of an affected parent, the concrete basis for the recurrence-risk counseling.
Multidisciplinary Surveillance
Action: Supportive CareNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Supportive Care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. NCIT:C15747
Coordinated evaluation across genetics, audiology, cardiology and orthopedics at the time of diagnosis. The 2024 case report is essentially an argument for this: a heart murmur detected in infancy went unfollowed, the genetic diagnosis came years after presentation, and by the time the ductus arteriosus was characterized the accompanying pulmonary hypertension had made repair impossible. On the strength of a single case the cardiac-screening recommendation is provisional, but it is low-cost and the counterfactual harm is well documented.
Show evidence (2 references)
PMID:39850491 SUPPORT Human Clinical
"It also highlights the need for multidisciplinary collaboration and a holistic care model to improve patient outcomes."
States the authors' central management recommendation.
PMID:39850491 SUPPORT Human Clinical
"Considering the presence of pulmonary hypertension, the cardiologist determined that surgical repair of the PDA was not a viable option for the patient."
Documents the concrete harm of delayed cardiac assessment that motivates surveillance.
🔬

Diagnosis

3
PAX3 sequencing and deletion/duplication analysis
Molecular confirmation rests on PAX3 analysis. Sanger or exome sequencing of the coding exons and flanking intronic boundaries detects the paired-domain missense alleles; because a whole-gene 2q36.1 deletion has produced an overlapping phenotype, chromosomal microarray or another copy-number method should be paired with sequencing rather than used only after a negative sequencing result. Whole-exome sequencing has the added value of excluding phenocopies, as when more than 100 congenital-heart-disease genes were screened in the patient with patent ductus arteriosus.
Show evidence (2 references)
PMID:18553554 SUPPORT Human Clinical
"All 9 exons and 20 bp of the flanking introns of the PAX3 gene were amplified by polymerase chain reaction (PCR)"
Describes the PAX3 sequencing approach used to evaluate a suspected CDHS phenotype.
PMID:24839464 SUPPORT Human Clinical
"Microarray analysis showed ~862 kb de novo deletion at 2q36.1 including PAX3."
Demonstrates that copy-number analysis detects PAX3 lesions that sequencing would miss.
Craniofacial and hand radiography
Skull and facial radiographs showing absent or small nasal bones with a small maxilla over a normal calvarium, together with hand and wrist films showing ulnar deviation and a hypoplastic ulnar styloid, constitute the imaging signature historically used to separate CDHS from Waardenburg syndrome type 3.
Show evidence (1 reference)
PMID:6859126 SUPPORT Human Clinical
"Common radiographic manifestations include small maxilla, absent or small nasal bones, and ulnar deviation of the hands."
Establishes the diagnostic radiographic findings.
Audiometric assessment
Audiometry (with auditory brainstem response testing in infancy) confirms and grades the bilateral sensorineural hearing loss. Universal newborn hearing screening is the practical entry point, since deafness is usually the earliest and most actionable finding.
Show evidence (1 reference)
PMID:39850491 SUPPORT Human Clinical
"subsequent otoscopic examination revealed moderate to severe neurosensorial hearing loss in the right ear and profound"
Illustrates audiologic characterization of the hearing loss in a CDHS patient.
📊

Prevalence

1
Worldwide
Point Prevalence 0.1 per 100,000 <1 in 1,000,000
Reported as a prevalence of less than 1 in 1,000,000. This is a qualitative rarity statement rather than a registry-derived rate: fewer than ten individuals have been described worldwide since 1983. The rate_per_100000 value is an upper-bound normalization of "<1 in 1,000,000" and should not be treated as a measured point estimate.
Show evidence (1 reference)
PMID:39850491 SUPPORT Human Clinical
"The craniofacial-deafness-hand syndrome is an extremely rare autosomal dominant disorder with a prevalence of less than 1 in"
Gives the published prevalence band for CDHS.
🔀

Differential Diagnoses

2

Conditions with similar clinical presentations that must be differentiated from Craniofacial-Deafness-Hand Syndrome:

PAX3-negative craniofacial-deafness spectrum
Overlapping Features A 37-year-old woman with congenital sensorineural hearing loss, dystopia canthorum, a flat facial profile, ulnar deviation with digit contractures and fifth-finger clinodactyly — features overlapping both CDHS and Waardenburg syndrome type 3 — had no mutation in any PAX3 coding exon or splice boundary, with whole-gene deletion excluded by SNP heterozygosity. Craniofacial CT showed markedly hypoplastic-to-aplastic paranasal sinuses, underdeveloped mastoids and small cochleae with only 1.5 turns, findings not previously associated with Waardenburg syndrome. This case raises the possibility of locus heterogeneity within the CDHS-like phenotype.
Distinguishing Features
  • Normal hand and wrist radiographs and normal nasal bones on CT — the two radiographic features that define CDHS.
  • Paranasal sinus, mastoid and cochlear anomalies not described in CDHS.
  • No detectable PAX3 coding or splice-site lesion, with whole-gene deletion excluded.
Show evidence (2 references)
PMID:18553554 SUPPORT Human Clinical
"Here we describe a woman who shares some, but not all features of WS type 3 and CDHS, and who also has abnormal cranial bones. All sinuses were hypoplastic, and the cochlea were small. No sequence alteration in PAX3 was found."
Documents a CDHS-overlapping phenotype without a PAX3 coding lesion.
PMID:18553554 SUPPORT Human Clinical
"These observations broaden the clinical range of WS and suggest there may be genetic heterogeneity even within the CDHS subtype."
States the locus-heterogeneity hypothesis for the CDHS-like phenotype.
🐁

Animal Models

1
Pax3 splotch (Sp) mutant Mus musculus
The splotch mouse carries a spontaneous intron 3 splice-acceptor mutation in Pax-3 that generates four aberrantly spliced transcripts, none expected to yield functional protein. It is the classic Pax3 loss-of-function model and reproduces neural tube closure defects (exencephaly, spina bifida). A separate Pax3-Cre knock-in disruption model shows a foreshortened cochlea, malformed vestibular apparatus and loss of stria vascularis intermediate cells. Note the model-fidelity limits: splotch is a loss-of-function allele, whereas CDHS is caused by paired-domain missense substitutions proposed to be more damaging than simple loss of function, and no model carries a CDHS allele (N47K or T31P) or reproduces the full human triad.
Species
Mus musculus
Genotype
Pax3 splotch (Sp) mutant
Genes
PAX3 hgnc:8617 HUGO Gene Nomenclature Committee (hgnc) Relation: this experimental model concerns this gene This experimental model concerns PAX3 (hgnc:8617). hgnc:8617 is a gene from the HUGO Gene Nomenclature Committee.
Show evidence (2 references)
PMID:8421686 SUPPORT Model Organism
"These aberrantly spliced mRNA transcripts are not expected to result in functional Pax-3 proteins and are thus responsible for the phenotype observed in the Sp mouse mutant."
Establishes splotch as a Pax3 loss-of-function model.
PMID:38278860 SUPPORT Model Organism
"we found that Pax3 deficiency causes foreshortened cochlea, malformed vestibular apparatus, and neural tube defects"
Documents the inner-ear phenotype of murine Pax3 disruption, the closest available model support for the CDHS deafness mechanism.
{ }

Source YAML

click to show 
name: Craniofacial-Deafness-Hand Syndrome
category: Mendelian
creation_date: "2026-07-31T00:00:00Z"
synonyms:
- CDHS
- Sommer-Young-Wee-Frye syndrome
- craniofacial deafness hand syndrome
description: >-
  Craniofacial-deafness-hand syndrome (CDHS) is an ultra-rare autosomal dominant
  multiple congenital anomaly syndrome caused by heterozygous missense variants in
  the paired domain of PAX3, the same neural-crest transcription factor whose
  loss-of-function alleles cause Waardenburg syndrome types 1 and 3. The cardinal
  triad is (1) a distinctive craniofacial gestalt — flat facial profile over a
  normal calvarium, hypertelorism, short downslanting palpebral fissures, a
  depressed nasal bridge with a button tip and slit-like nares, a small "pursed"
  mouth, and radiographically absent or hypoplastic nasal bones with a small
  maxilla; (2) profound sensorineural hearing loss; and (3) ulnar deviation of the
  hands with flexion contractures of the third through fifth digits and limited
  wrist movement. CDHS is allelic to, but clinically distinct from, Waardenburg
  syndrome: the founding family characteristically lacked the classic Waardenburg
  pigmentary stigmata (white forelock, heterochromia iridis), and the imaging
  findings — absent/hypoplastic nasal bones and a hypoplastic ulnar styloid over a
  normal calvarium — were considered the discriminating feature. The evidence base
  is exceptionally small: three affected individuals across two generations of one
  family carrying the PAX3 Asn47Lys allele, plus a handful of later single-case
  reports, giving a reported prevalence below 1 in 1,000,000.
disease_term:
  preferred_term: craniofacial-deafness-hand syndrome
  term:
    id: MONDO:0007395
    label: craniofacial-deafness-hand syndrome
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0007395
      label: craniofacial-deafness-hand syndrome
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO
parents:
- multiple congenital anomalies/dysmorphic syndrome without intellectual disability
- hereditary disease
- Sensorineural Hearing Loss
inheritance:
- name: Autosomal dominant
  inheritance_term:
    preferred_term: autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  description: >-
    CDHS segregates as an autosomal dominant trait. In the founding family the
    phenotype was transmitted from an affected mother to two of her children,
    giving three affected individuals across two generations. The two later
    molecularly characterized patients (a PAX3 p.Thr31Pro missense variant and a
    de novo 2q36.1 deletion encompassing PAX3) were simplex cases with unaffected
    parents, so both inherited and de novo dominant mechanisms are documented.
  evidence:
  - reference: PMID:8664898
    reference_title: Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Craniofacial-deafness-hand syndrome (MIM 122880) is inherited as an
      autosomal dominant mutation
    explanation: >-
      States the autosomal dominant mode of inheritance for CDHS directly.
  - reference: PMID:14556253
    reference_title: Craniofacial-deafness-hand syndrome revisited.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Because of three affected family members in two generations and a phenotype
      of midfacial anomalies and dystopia canthorum resembling Waardenburg
      syndrome, a search for mutations in the PAX3 gene was undertaken.
    explanation: >-
      Documents vertical transmission across two generations in the founding
      family, consistent with dominant inheritance.
prevalence:
- population: Worldwide
  measure_type: POINT_PREVALENCE
  prevalence_class: BELOW_1_IN_1000000
  rate_per_100000: 0.1
  notes: >-
    Reported as a prevalence of less than 1 in 1,000,000. This is a qualitative
    rarity statement rather than a registry-derived rate: fewer than ten
    individuals have been described worldwide since 1983. The rate_per_100000
    value is an upper-bound normalization of "<1 in 1,000,000" and should not be
    treated as a measured point estimate.
  evidence:
  - reference: PMID:39850491
    reference_title: "Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms and lack of holistic care."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The craniofacial-deafness-hand syndrome is an extremely rare autosomal
      dominant disorder with a prevalence of less than 1 in
    explanation: >-
      Gives the published prevalence band for CDHS.
pathophysiology:
- name: PAX3 Paired-Domain Missense Variant
  description: >-
    CDHS is caused by heterozygous missense substitution within the paired domain,
    the N-terminal sequence-specific DNA-binding module of the PAX3 transcription
    factor. The founding family carries Asn47Lys (N47K) in exon 2; a second,
    unrelated patient carries p.Thr31Pro (c.A91C) in the same domain. The identity
    of the substitution matters: a different substitution at the very same codon,
    Asn47His, causes Waardenburg syndrome type 3 rather than CDHS, so CDHS is
    defined by an allele class rather than simply by PAX3 dysfunction.
  biological_scale: MOLECULAR
  genes:
  - preferred_term: PAX3
    term:
      id: hgnc:8617
      label: PAX3
  molecular_functions:
  - preferred_term: sequence-specific DNA binding
    term:
      id: GO:0043565
      label: sequence-specific DNA binding
    modifier: DECREASED
  evidence:
  - reference: PMID:8664898
    reference_title: Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In a family of three affected individuals with this syndrome, a mother and
      two children, a missense mutation (Asn47Lys) in the paired domain of PAX3
      was initially detected by SSCP analysis.
    explanation: >-
      Identifies the causal paired-domain missense allele in the founding CDHS
      family.
  - reference: PMID:8664898
    reference_title: Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A previously described missense mutation in this same codon (Asn47His) is
      associated with Waardenburg syndrome type 3 (Hoth et al., 1993).
    explanation: >-
      Establishes that the specific amino-acid substitution at codon 47, not
      merely the affected codon, determines whether the phenotype is CDHS or
      Waardenburg syndrome type 3.
  - reference: PMID:39850491
    reference_title: "Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms and lack of holistic care."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patient's variant is found within the conserved paired box domain (PB)
    explanation: >-
      Confirms that the second reported CDHS allele also lies in the paired
      domain, supporting a domain-restricted allele class.
  downstream:
  - target: Altered Paired-Domain DNA Recognition
    causal_link_type: DIRECT
- name: Altered Paired-Domain DNA Recognition
  description: >-
    The paired domain comprises two helix-turn-helix subdomains whose C-terminal
    recognition helices make base-specific contacts in the DNA major groove.
    Substitution of a basic residue for the asparagine at position 47 — a residue
    conserved across all known murine Pax and human PAX genes — perturbs this
    base-specific readout. The resulting change in PAX3 transcriptional output is
    proposed to be more damaging than the haploinsufficiency produced by the
    missense, frameshift and deletion alleles that cause Waardenburg syndrome type
    1, which is the mechanistic rationale for the distinct CDHS phenotype.
  biological_scale: MOLECULAR
  molecular_functions:
  - preferred_term: DNA-binding transcription factor activity
    term:
      id: GO:0003700
      label: DNA-binding transcription factor activity
    modifier: ABNORMAL
  mechanism_confidence: HYPOTHETICAL
  evidence:
  - reference: PMID:8664898
    reference_title: Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Substitution of a basic amino acid for asparagine at residue 47, conserved
      in all known murine Pax and human PAX genes, appears to have a more drastic
      effect on the phenotype than missense, frameshift and deletion mutations of
      PAX3 that cause Waardenburg syndrome type 1.
    explanation: >-
      States the proposed allele-severity model linking the specific
      paired-domain substitution to the more severe CDHS phenotype.
  - reference: PMID:20643146
    reference_title: The PAX3 paired domain and homeodomain function as a single binding module in vivo to regulate subnuclear localization and mobility by a mechanism that requires base-specific recognition.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      At the structural level, this reflected an unexpected dependence on
      base-specific contacts in the PD
    explanation: >-
      Cell-based structure-function work showing that paired-domain function
      depends on base-specific DNA contacts, the class of interaction disrupted
      by the CDHS residue-47 substitution. Indirect: the specific CDHS alleles
      were not assayed, so this supports the general mechanism rather than the
      CDHS variant itself.
  downstream:
  - target: Cranial Neural Crest Patterning Failure
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - >-
      Altered transactivation of PAX3 target genes in premigratory and migratory
      neural crest; the specific dysregulated targets in CDHS have not been
      identified.
  - target: Somitic and Limb Musculoskeletal Patterning Disturbance
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - >-
      Altered transactivation of PAX3 target genes in the dermomyotome and in
      the limb muscle precursors that delaminate from it; not demonstrated in
      CDHS patients.
- name: Cranial Neural Crest Patterning Failure
  description: >-
    PAX3 specifies dorsal neural tube progenitors and is required for the
    induction, survival, migration and differentiation of neural crest cells.
    Disrupted PAX3 transcriptional output during the narrow embryonic window of
    neural crest patterning is the proposed common origin of the CDHS triad: the
    craniofacial skeleton, the melanocytic component of the inner ear, and — in
    the one reported case with cardiac involvement — the cardiac outflow tract are
    all neural-crest derivatives. This node is inferred from PAX3 developmental
    biology and model-organism data rather than from tissue studies of CDHS
    patients.
  biological_scale: CELLULAR
  cell_types:
  - preferred_term: migratory cranial neural crest cell
    term:
      id: CL:0000008
      label: migratory cranial neural crest cell
  biological_processes:
  - preferred_term: neural crest cell development
    term:
      id: GO:0014032
      label: neural crest cell development
    modifier: ABNORMAL
  - preferred_term: neural crest cell migration
    term:
      id: GO:0001755
      label: neural crest cell migration
    modifier: ABNORMAL
  mechanism_confidence: HYPOTHETICAL
  evidence:
  - reference: PMID:39850491
    reference_title: "Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms and lack of holistic care."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      During development, this protein is expressed in skeletal muscle, the
      central nervous system, and neural crest
    explanation: >-
      Establishes PAX3 expression in neural crest derivatives as the
      developmental context for the CDHS phenotype.
  - reference: PMID:26410165
    reference_title: PAX transcription factors in neural crest development.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      highlighted the role of PAX3 and PAX7 in neural crest induction
    explanation: >-
      Supports the induction limb of this node's claim, which the
      expression-only quote above does not cover. Review article, hence OTHER.
  - reference: PMID:29730428
    reference_title: The expression and function of PAX3 in development and disease.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Germline mutations of the murine Pax3 and human PAX3 genes cause
      deficiencies in these developmental lineages
    explanation: >-
      Supports the requirement claim rather than mere expression: germline PAX3
      lesions produce deficiencies in the neural crest and skeletal muscle
      lineages named in the preceding sentence of the same abstract.
  downstream:
  - target: Craniofacial Skeletal Hypoplasia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Cochlear Melanocyte Deficiency
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Craniofacial Skeletal Hypoplasia
  description: >-
    Failure of neural-crest-derived membranous bone formation in the midface
    produces the radiographic hallmark of CDHS — absent or hypoplastic nasal bones
    with a small maxilla over a normal calvarium. The soft-tissue gestalt (flat
    facial profile, depressed nasal bridge with button tip and slit-like nares,
    small pursed mouth) follows from the underlying skeletal deficiency.
  biological_scale: TISSUE
  locations:
  - preferred_term: nasal bone
    term:
      id: UBERON:0001681
      label: nasal bone
  biological_processes:
  - preferred_term: embryonic cranial skeleton morphogenesis
    term:
      id: GO:0048701
      label: embryonic cranial skeleton morphogenesis
    modifier: ABNORMAL
  evidence:
  - reference: PMID:6859126
    reference_title: Previously undescribed syndrome of craniofacial, hand anomalies, and sensorineural deafness.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Common radiographic manifestations include small maxilla, absent or small
      nasal bones, and ulnar deviation of the hands.
    explanation: >-
      The original description documents the midfacial skeletal hypoplasia that
      defines this node.
- name: Somitic and Limb Musculoskeletal Patterning Disturbance
  description: >-
    The hand arm of the CDHS triad cannot derive from the cranial neural crest
    node: the wrist skeleton and limb musculature are somite and lateral-plate
    derivatives, not cranial neural crest. PAX3 has a separate, well-established
    role in this second lineage — it is expressed in the lateral dermomyotome
    that gives rise to limb muscle progenitors, and murine Pax3 loss produces
    limbs without musculature. The same upper-limb musculoskeletal involvement
    separates Waardenburg syndrome type 3 from type 1, so a shared PAX3-dependent
    limb mechanism is the natural reading of the CDHS hand phenotype.

    This node is HYPOTHETICAL and deliberately broad. No study has examined limb
    or muscle tissue from a CDHS patient, and the myogenic route does not by
    itself account for the skeletal element of the phenotype (the hypoplastic
    ulnar styloid), which is why the accompanying knowledge-gap discussion keeps
    that specific question open rather than treating this node as settled.
  biological_scale: TISSUE
  mechanism_confidence: HYPOTHETICAL
  biological_processes:
  - preferred_term: skeletal muscle tissue development
    term:
      id: GO:0007519
      label: skeletal muscle tissue development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:7744814
    reference_title: Pax3 inhibits myogenic differentiation of cultured myoblast cells.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Pax3 is an evolutionarily conserved transcription factor expressed in the
      lateral dermomyotome, a region that gives rise to limb muscle progenitors.
    explanation: >-
      Establishes the somitic/limb lineage in which PAX3 acts, distinct from the
      cranial neural crest lineage of the sibling node. PARTIAL because it is
      murine and general PAX3 biology, not CDHS-specific.
  - reference: PMID:7744814
    reference_title: Pax3 inhibits myogenic differentiation of cultured myoblast cells.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Mutations in Pax-3 account for the mouse mutant Splotch which develops
      without limb musculature.
    explanation: >-
      Demonstrates that Pax3 loss produces a limb phenotype in vivo, supplying
      the mechanistic plausibility for this node. PARTIAL: a murine null allele,
      not the human CDHS missense allele class.
  - reference: PMID:29730428
    reference_title: The expression and function of PAX3 in development and disease.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      This protein is expressed during development of skeletal muscle, central
      nervous system and neural crest derivatives, and regulates expression of
      target genes that impact on proliferation, survival, differentiation and
      motility in these lineages.
    explanation: >-
      Names skeletal muscle as a PAX3-dependent lineage alongside neural crest,
      which is the basis for modelling the hand arm as a separate branch rather
      than as a downstream consequence of the cranial neural crest node.
  downstream:
  - target: Ulnar Deviation of the Hand
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - >-
      Presumed imbalance of limb musculature and periarticular soft tissue;
      never demonstrated in a CDHS patient.
  - target: Flexion Contractures of the Fingers
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - >-
      Presumed imbalance of limb musculature and periarticular soft tissue;
      never demonstrated in a CDHS patient.
  - target: Limited Wrist Movement
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Cochlear Melanocyte Deficiency
  description: >-
    Cochlear melanocytes are the intermediate cells of the stria vascularis and
    generate the endocochlear potential on which mechanotransduction depends. They
    derive from neural crest, and in the mouse they arise from Pax3-traced
    melanoblasts and Plp1-traced Schwann cell precursors. Loss of Pax3 in the mouse
    significantly diminishes these cells, providing the leading mechanism for the
    profound sensorineural hearing loss shared by CDHS and the other PAX3-related
    disorders. This node rests on model-organism evidence; the cochlea has not been
    examined in a CDHS patient.
  biological_scale: CELLULAR
  cell_types:
  - preferred_term: cochlear melanocyte (stria vascularis intermediate cell)
    term:
      id: CL:0000148
      label: melanocyte
  locations:
  - preferred_term: internal ear
    term:
      id: UBERON:0001846
      label: internal ear
  biological_processes:
  - preferred_term: inner ear morphogenesis
    term:
      id: GO:0042472
      label: inner ear morphogenesis
    modifier: ABNORMAL
  mechanism_confidence: HYPOTHETICAL
  evidence:
  - reference: PMID:38278860
    reference_title: Loss of Pax3 causes reduction of melanocytes in the developing mouse cochlea.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Lineage tracing and in situ hybridization show that Pax3+ derivatives
      contribute to S100+, Kir4.1+ and Dct+ melanocytes (intermediate cells) in
      the developing stria vascularis, all of which are significantly diminished
      in Pax3 mutant animals.
    explanation: >-
      Mouse lineage-tracing evidence that Pax3 is required for cochlear
      melanocyte development, the proposed basis of the hearing loss.
  - reference: PMID:38278860
    reference_title: Loss of Pax3 causes reduction of melanocytes in the developing mouse cochlea.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Cochlear melanocytes are intermediate cells in the stria vascularis that
      generate endocochlear potentials required for auditory function.
    explanation: >-
      Explains why depletion of this cell population causes sensorineural
      hearing loss.
  - reference: PMID:24565836
    reference_title: Pax3 function is required specifically for inner ear structures with melanogenic fates.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      suggesting that Pax3 lineage with a melanogenic fate migrated to the inner
      ear, yet failed to differentiate and survive without Pax3 function
    explanation: >-
      Independent murine fate-mapping evidence narrowing the defect to the
      melanogenic lineage: Pax3-lineage cells reach the inner ear but do not
      differentiate or survive, which is more specific than a general
      migration failure.
  downstream:
  - target: Profound Sensorineural Hearing Loss
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - >-
      Reduced endocochlear potential and impaired hair-cell mechanotransduction;
      not measured in CDHS patients.
phenotypes:
- category: Craniofacial
  name: Absent or Hypoplastic Nasal Bones
  description: >-
    The radiographic hallmark of CDHS. Skull films show absent or small nasal
    bones over a normal calvarium, accompanied by a small maxilla. Together with
    the hypoplastic ulnar styloid, this imaging signature was considered the
    feature that distinguishes CDHS from Waardenburg syndrome type 3.
  phenotype_term:
    preferred_term: Aplasia/Hypoplasia of the nasal bone
    term:
      id: HP:0010940
      label: Aplasia/Hypoplasia of the nasal bone
  frequency: VERY_FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:8664898
    reference_title: Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      characterized by the absence or hypoplasia of the nasal bones
    explanation: >-
      Names absent/hypoplastic nasal bones as a defining feature of CDHS.
  - reference: PMID:18553554
    reference_title: "Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      unique imaging findings of absence or hypoplasia of the nasal bones and a
      hypoplastic ulnar styloid
    explanation: >-
      Independent review of the founding family's imaging phenotype, and the
      basis for the frequency assignment (present in all affected individuals of
      the only well-characterized family).
- category: Craniofacial
  name: Hypoplasia of the Maxilla
  description: >-
    A small maxilla was documented radiographically in the original
    mother-daughter pair and contributes to the flat facial profile.
  phenotype_term:
    preferred_term: Hypoplasia of the maxilla
    term:
      id: HP:0000327
      label: Hypoplasia of the maxilla
  evidence:
  - reference: PMID:6859126
    reference_title: Previously undescribed syndrome of craniofacial, hand anomalies, and sensorineural deafness.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Common radiographic manifestations include small maxilla
    explanation: >-
      Documents maxillary hypoplasia in the original description.
- category: Craniofacial
  name: Flat Facial Profile
  description: >-
    A flat facial profile over a normal calvarium is the immediate visual
    impression in CDHS and reflects the underlying midfacial skeletal hypoplasia.
  phenotype_term:
    preferred_term: Flat face
    term:
      id: HP:0012368
      label: Flat face
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:14556253
    reference_title: Craniofacial-deafness-hand syndrome revisited.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The syndrome consisted of a normal calvarium with a flat facial profile
    explanation: >-
      States the flat facial profile with normal calvarium as a core feature.
- category: Craniofacial
  name: Hypertelorism
  description: >-
    Increased interocular distance, present in all affected members of the
    founding family and in later reported patients.
  phenotype_term:
    preferred_term: Hypertelorism
    term:
      id: HP:0000316
      label: Hypertelorism
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:6859126
    reference_title: Previously undescribed syndrome of craniofacial, hand anomalies, and sensorineural deafness.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Both mother and child have a flat facial profile, hypertelorism,
      hypoplastic nose with slit-like nares, and a sensorineural hearing loss.
    explanation: >-
      Documents hypertelorism in both originally described individuals.
- category: Craniofacial
  name: Short Palpebral Fissures
  description: >-
    Small (short) palpebral fissures are part of the recognizable CDHS periorbital
    gestalt.
  phenotype_term:
    preferred_term: Short palpebral fissure
    term:
      id: HP:0012745
      label: Short palpebral fissure
  evidence:
  - reference: PMID:8664898
    reference_title: Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      hypertelorism, short palpebral fissures
    explanation: >-
      Names short palpebral fissures among the defining CDHS features.
- category: Craniofacial
  name: Downslanted Palpebral Fissures
  description: >-
    The palpebral fissures slant downward laterally; the original reports use the
    older clinical term "antimongoloid slant" for this finding.
  phenotype_term:
    preferred_term: Downslanted palpebral fissures
    term:
      id: HP:0000494
      label: Downslanted palpebral fissures
  evidence:
  - reference: PMID:14556253
    reference_title: Craniofacial-deafness-hand syndrome revisited.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      hypertelorism and small palpebral fissures with an antimongoloid slant
    explanation: >-
      "Antimongoloid slant" is the older clinical term for downslanted palpebral
      fissures.
- category: Craniofacial
  name: Depressed Nasal Bridge
  description: >-
    A depressed nasal bridge with a characteristic "button" nasal tip.
  phenotype_term:
    preferred_term: Depressed nasal bridge
    term:
      id: HP:0005280
      label: Depressed nasal bridge
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:14556253
    reference_title: Craniofacial-deafness-hand syndrome revisited.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a depressed nasal bridge with a button tip and slitlike nares
    explanation: >-
      Documents the depressed nasal bridge as a core craniofacial feature.
- category: Craniofacial
  name: Narrow Nares
  description: >-
    Slit-like nares accompanying the small, short, hypoplastic nose.
  phenotype_term:
    preferred_term: Narrow naris
    term:
      id: HP:0009933
      label: Narrow naris
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:8664898
    reference_title: Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a small and short nose with slitlike nares
    explanation: >-
      Documents the slit-like nares of the hypoplastic CDHS nose.
- category: Craniofacial
  name: Short Nose
  description: >-
    The nose is small and short, consistent with the underlying nasal bone
    hypoplasia.
  phenotype_term:
    preferred_term: Short nose
    term:
      id: HP:0003196
      label: Short nose
  evidence:
  - reference: PMID:8664898
    reference_title: Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a small and short nose with slitlike nares
    explanation: >-
      Documents the short nose in CDHS.
- category: Craniofacial
  name: Narrow Mouth
  description: >-
    A small, "pursed" mouth is part of the recognizable CDHS facial gestalt.
  phenotype_term:
    preferred_term: Narrow mouth
    term:
      id: HP:0000160
      label: Narrow mouth
  evidence:
  - reference: PMID:14556253
    reference_title: Craniofacial-deafness-hand syndrome revisited.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a small "pursed" mouth
    explanation: >-
      Documents the small pursed mouth of CDHS.
- category: Craniofacial
  name: Dystopia Canthorum
  description: >-
    Lateral displacement of the inner canthi, the feature that defines Waardenburg
    syndrome type 1, was also present in the CDHS family and prompted the original
    PAX3 candidate-gene search. "Dystopia canthorum" is an exact synonym of the
    HPO term Telecanthus (HP:0000506).
  phenotype_term:
    preferred_term: Dystopia canthorum
    term:
      id: HP:0000506
      label: Telecanthus
  evidence:
  - reference: PMID:14556253
    reference_title: Craniofacial-deafness-hand syndrome revisited.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a phenotype of midfacial anomalies and dystopia canthorum resembling
      Waardenburg syndrome
    explanation: >-
      Documents dystopia canthorum in the CDHS family, and the reasoning that led
      to PAX3 testing.
- category: Auditory
  name: Profound Sensorineural Hearing Loss
  description: >-
    Profound, bilateral sensorineural hearing loss is the most functionally
    significant feature and is present in every reported patient. It was congenital
    in the founding family; in the single later patient with a p.Thr31Pro variant
    the loss was recognized at age eight and was asymmetric (moderate-to-severe on
    the right, profound on the left), so the age at recognition is more variable
    than the original description implied.
  phenotype_term:
    preferred_term: Profound sensorineural hearing impairment
    term:
      id: HP:0011476
      label: Profound sensorineural hearing impairment
  frequency: VERY_FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:8664898
    reference_title: Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      profound sensorineural deafness
    explanation: >-
      Names profound sensorineural deafness as a defining CDHS feature.
  - reference: PMID:14556253
    reference_title: Craniofacial-deafness-hand syndrome revisited.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Profound sensorineural hearing loss and ulnar deviation of the hands with
      flexion contractures of digits three, four and five was evident.
    explanation: >-
      Confirms profound sensorineural hearing loss on 20-year follow-up of the
      founding family; the basis for the VERY_FREQUENT band, since it was present
      in all affected members.
- category: Skeletal
  name: Ulnar Deviation of the Hand
  description: >-
    Ulnar deviation of the hands and fingers is the third element of the CDHS
    triad and, with the hypoplastic ulnar styloid, forms the characteristic hand
    radiograph.
  phenotype_term:
    preferred_term: Ulnar deviation of the hand
    term:
      id: HP:0009487
      label: Ulnar deviation of the hand
  frequency: VERY_FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:6859126
    reference_title: Previously undescribed syndrome of craniofacial, hand anomalies, and sensorineural deafness.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Common radiographic manifestations include small maxilla, absent or small
      nasal bones, and ulnar deviation of the hands.
    explanation: >-
      Documents ulnar deviation of the hands in the original description.
  - reference: PMID:14556253
    reference_title: Craniofacial-deafness-hand syndrome revisited.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      ulnar deviation of the hands with flexion contractures of digits three,
      four and five was evident
    explanation: >-
      Confirms ulnar deviation across the founding family on long-term follow-up.
- category: Skeletal
  name: Flexion Contractures of the Fingers
  description: >-
    Flexion contractures affecting the third, fourth and fifth digits.
  phenotype_term:
    preferred_term: Flexion contracture of finger
    term:
      id: HP:0012785
      label: Flexion contracture of finger
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:14556253
    reference_title: Craniofacial-deafness-hand syndrome revisited.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      flexion contractures of digits three, four and five
    explanation: >-
      Documents the digit-specific flexion contractures of CDHS.
- category: Skeletal
  name: Limited Wrist Movement
  description: >-
    Restricted movement at the wrist accompanies the ulnar deviation.
  phenotype_term:
    preferred_term: Limited wrist movement
    term:
      id: HP:0006248
      label: Limited wrist movement
  evidence:
  - reference: PMID:8664898
    reference_title: Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      limited movement at the wrist and ulnar deviations of the fingers
    explanation: >-
      Documents limited wrist movement as a defining CDHS feature.
- category: Skeletal
  name: Hypoplastic Ulnar Styloid Process
  description: >-
    A hypoplastic ulnar styloid process is the wrist counterpart of the absent
    nasal bones and completes the radiographic signature that was used to separate
    CDHS from Waardenburg syndrome type 3.
  phenotype_term:
    preferred_term: Abnormal ulnar styloid process morphology
    term:
      id: HP:0004035
      label: Abnormal ulnar styloid process morphology
  diagnostic: true
  evidence:
  - reference: PMID:18553554
    reference_title: "Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      unique imaging findings of absence or hypoplasia of the nasal bones and a
      hypoplastic ulnar styloid
    explanation: >-
      Documents the hypoplastic ulnar styloid as part of the distinguishing CDHS
      imaging phenotype.
- category: Skeletal
  name: Clinodactyly of the 5th Finger
  description: >-
    Fifth-finger clinodactyly with shortening was reported in the patient carrying
    the p.Thr31Pro variant.
  phenotype_term:
    preferred_term: Clinodactyly of the 5th finger
    term:
      id: HP:0004209
      label: Clinodactyly of the 5th finger
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:39850491
    reference_title: "Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms and lack of holistic care."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      as well as shortening and clinodactyly of the
    explanation: >-
      Documents fifth-finger clinodactyly in the p.Thr31Pro patient. Frequency is
      set to OCCASIONAL because it is reported in one of the small number of
      published patients and was not part of the founding family's description.
- category: Cardiovascular
  name: Patent Ductus Arteriosus
  description: >-
    Patent ductus arteriosus with secondary severe pulmonary hypertension,
    cardiomegaly and valvular insufficiency was reported in a single 21-year-old
    patient with a novel PAX3 p.Thr31Pro variant. Sequencing of more than 100
    congenital-heart-disease genes found no alternative explanation, and the
    authors invoked PAX3's role in cardiac neural crest. This remains a
    single-case, unreplicated association and should not be treated as a core CDHS
    feature; the authors nonetheless argue it justifies cardiac screening at
    diagnosis.
  phenotype_term:
    preferred_term: Patent ductus arteriosus
    term:
      id: HP:0001643
      label: Patent ductus arteriosus
  frequency: VERY_RARE
  evidence:
  - reference: PMID:39850491
    reference_title: "Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms and lack of holistic care."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Craniofacial-Deafness-Hand Syndrome associated with a PAX3
      variation and PDA, highlighting the gene
    explanation: >-
      Documents PDA in a molecularly confirmed CDHS patient. The full sentence
      in the source states this is the first such report, which is the basis for
      the VERY_RARE band and for treating the association as emerging.
- category: Cardiovascular
  name: Pulmonary Arterial Hypertension
  description: >-
    Severe pulmonary hypertension developed in the same patient as a consequence
    of the long-unrepaired ductus arteriosus, and by age 21 had rendered surgical
    closure non-viable.
  phenotype_term:
    preferred_term: Pulmonary arterial hypertension
    term:
      id: HP:0002092
      label: Pulmonary arterial hypertension
  frequency: VERY_RARE
  evidence:
  - reference: PMID:39850491
    reference_title: "Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms and lack of holistic care."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the echocardiogram demonstrated evidence of PDA, severe pulmonary
      hypertension, and valvular insuf
    explanation: >-
      Documents the pulmonary hypertension and its echocardiographic basis.
genetic:
- name: PAX3
  gene_term:
    preferred_term: PAX3
    term:
      id: hgnc:8617
      label: PAX3
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  notes: >-
    PAX3 (2q36.1) encodes a paired-box/homeodomain transcription factor. CDHS
    alleles cluster in the paired domain encoded by exon 2. The same gene causes
    Waardenburg syndrome types 1 and 3; ClinGen's PAX3-Waardenburg gene-disease
    validity assertion explicitly scopes CDHS out, which is why CDHS is curated as
    a separate dismech entry rather than as a Waardenburg subtype.
  evidence:
  - reference: PMID:8664898
    reference_title: Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      PCR amplification using an oligonucleotide with a terminal 3'-residue match
      for the C-to-G transversion in codon 47 showed the presence of this
      mutation in the DNA from all affected members.
    explanation: >-
      Demonstrates cosegregation of the PAX3 codon-47 variant with the CDHS
      phenotype in the founding family.
  - reference: PMID:18553554
    reference_title: "Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      CDHS is also an allelic variant, and may be caused by PAX3 mutations
      affecting the paired box domain
    explanation: >-
      Independent statement that CDHS is a PAX3 paired-domain allelic disorder.
variants:
- name: PAX3 p.Asn47Lys (N47K)
  description: >-
    The founding CDHS allele, a missense substitution in the paired domain encoded
    by exon 2, arising from a C-to-G transversion in codon 47. It cosegregated
    with the phenotype in all three affected members of the reported family and
    was absent from unaffected members. Its clinical significance is anchored by
    the contrast with Asn47His at the same codon, which causes Waardenburg
    syndrome type 3.
  gene:
    preferred_term: PAX3
    term:
      id: hgnc:8617
      label: PAX3
  type: missense
  clinical_significance: PATHOGENIC
  evidence:
  - reference: PMID:8664898
    reference_title: Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a missense mutation (Asn47Lys) in the paired domain of PAX3 was initially
      detected by SSCP analysis
    explanation: >-
      Identifies the variant and its domain location.
  - reference: PMID:8664898
    reference_title: Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The DNA from unaffected members were refractory to PCR amplification with
      the mutation-specific oligonucleotide but did amplify a control primer pair
      in the same PCR reaction tube.
    explanation: >-
      Establishes absence of the variant in unaffected relatives, supporting
      pathogenicity.
- name: PAX3 c.91A>C p.Thr31Pro (T31P)
  description: >-
    A novel de novo paired-domain missense variant identified by whole-exome
    sequencing in a 21-year-old Ecuadorian male, the second molecularly defined
    CDHS allele. It was absent from population databases, uniformly predicted
    damaging by in-silico tools, affects a residue conserved to zebrafish, and was
    classified pathogenic under ACMG criteria. The source publication contains an
    internal inconsistency in its variant prose, describing the substitution as
    "threonine-to-methionine" while giving p.T31P (proline) in the same sentence
    and throughout the rest of the paper; the protein change p.Thr31Pro is the one
    used consistently elsewhere in the report and is adopted here.
  gene:
    preferred_term: PAX3
    term:
      id: hgnc:8617
      label: PAX3
  type: missense
  clinical_significance: PATHOGENIC
  evidence:
  - reference: PMID:39850491
    reference_title: "Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms and lack of holistic care."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified a novel pathogenic missense variant in the PAX3 gene (c.A91C,
    explanation: >-
      Reports the variant and its pathogenic classification.
  - reference: PMID:39850491
    reference_title: "Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms and lack of holistic care."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: >-
      Conservation analysis showed the threonine residue is highly conserved
      across species, including zebra
    explanation: >-
      Conservation analysis supporting the pathogenicity classification. Tagged
      COMPUTATIONAL because this specific claim rests on sequence analysis rather
      than an experimental assay.
- name: 2q36.1 deletion encompassing PAX3
  description: >-
    An approximately 862 kb de novo deletion at 2q36.1 including PAX3 was found by
    microarray in a 16-year-old girl with hearing loss who lacked the major
    features of Waardenburg syndrome type 1 but whose phenotype overlapped CDHS.
    This is a whole-gene dosage lesion rather than a paired-domain missense allele,
    so it does not fit the allele-class model proposed for CDHS; the case is
    curated here as phenotypic overlap and a caution against treating the
    genotype-phenotype correlation as absolute, not as a confirmed third CDHS
    allele.
  gene:
    preferred_term: PAX3
    term:
      id: hgnc:8617
      label: PAX3
  type: deletion
  clinical_significance: PATHOGENIC
  evidence:
  - reference: PMID:24839464
    reference_title: PAX3 gene deletion detected by microarray analysis in a girl with hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report a 16 year old female presenting hearing loss and normal
      intellectual development, without major features of Waardenburg syndrome
      type 1, and without family history of the syndrome. Her phenotype, however,
      overlaps with features of craniofacial-deafness-hand syndrome.
    explanation: >-
      Documents a PAX3-deletion patient whose phenotype overlaps CDHS. Marked
      PARTIAL because the authors describe phenotypic overlap rather than
      asserting a CDHS diagnosis.
  - reference: PMID:24839464
    reference_title: PAX3 gene deletion detected by microarray analysis in a girl with hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Microarray analysis showed ~862 kb de novo deletion at 2q36.1 including
      PAX3.
    explanation: >-
      Establishes the size, location and de novo origin of the deletion.
diagnosis:
- name: PAX3 sequencing and deletion/duplication analysis
  description: >-
    Molecular confirmation rests on PAX3 analysis. Sanger or exome sequencing of
    the coding exons and flanking intronic boundaries detects the paired-domain
    missense alleles; because a whole-gene 2q36.1 deletion has produced an
    overlapping phenotype, chromosomal microarray or another copy-number method
    should be paired with sequencing rather than used only after a negative
    sequencing result. Whole-exome sequencing has the added value of excluding
    phenocopies, as when more than 100 congenital-heart-disease genes were screened
    in the patient with patent ductus arteriosus.
  evidence:
  - reference: PMID:18553554
    reference_title: "Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All 9 exons and 20 bp of the flanking introns of the PAX3 gene were
      amplified by polymerase chain reaction (PCR)
    explanation: >-
      Describes the PAX3 sequencing approach used to evaluate a suspected CDHS
      phenotype.
  - reference: PMID:24839464
    reference_title: PAX3 gene deletion detected by microarray analysis in a girl with hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Microarray analysis showed ~862 kb de novo deletion at 2q36.1 including
      PAX3.
    explanation: >-
      Demonstrates that copy-number analysis detects PAX3 lesions that sequencing
      would miss.
- name: Craniofacial and hand radiography
  description: >-
    Skull and facial radiographs showing absent or small nasal bones with a small
    maxilla over a normal calvarium, together with hand and wrist films showing
    ulnar deviation and a hypoplastic ulnar styloid, constitute the imaging
    signature historically used to separate CDHS from Waardenburg syndrome type 3.
  evidence:
  - reference: PMID:6859126
    reference_title: Previously undescribed syndrome of craniofacial, hand anomalies, and sensorineural deafness.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Common radiographic manifestations include small maxilla, absent or small
      nasal bones, and ulnar deviation of the hands.
    explanation: >-
      Establishes the diagnostic radiographic findings.
- name: Audiometric assessment
  description: >-
    Audiometry (with auditory brainstem response testing in infancy) confirms and
    grades the bilateral sensorineural hearing loss. Universal newborn hearing
    screening is the practical entry point, since deafness is usually the earliest
    and most actionable finding.
  evidence:
  - reference: PMID:39850491
    reference_title: "Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms and lack of holistic care."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      subsequent otoscopic examination revealed moderate to severe neurosensorial
      hearing loss in the right ear and profound
    explanation: >-
      Illustrates audiologic characterization of the hearing loss in a CDHS
      patient.
treatments:
- name: Hearing Rehabilitation
  description: >-
    Management of the profound congenital sensorineural hearing loss with
    amplification or cochlear implantation and accompanying speech-language
    habilitation. No CDHS-specific outcome data exist; this reflects the standard
    of care for congenital severe-to-profound sensorineural hearing loss and for
    the PAX3-related disorders generally.
  treatment_term:
    preferred_term: Rehabilitation
    term:
      id: NCIT:C15315
      label: Rehabilitation
  therapeutic_modality: BEHAVIORAL
  target_phenotypes:
  - preferred_term: Profound sensorineural hearing impairment
    term:
      id: HP:0011476
      label: Profound sensorineural hearing impairment
  notes: >-
    Curated as supportive standard of care. No publication reports hearing
    rehabilitation outcomes in a molecularly confirmed CDHS patient, so no
    evidence item is attached rather than citing a source that does not make the
    claim.
- name: Hand Therapy and Orthopedic Management
  description: >-
    Occupational and physical therapy for the digit flexion contractures and
    limited wrist movement, with surgical release considered case by case. As
    with hearing rehabilitation, no CDHS-specific outcome data exist; this is the
    standard of care for congenital hand contractures and is included so the
    third arm of the cardinal triad is not the only one without a management
    entry.
  treatment_term:
    preferred_term: Occupational Therapy
    term:
      id: NCIT:C121351
      label: Occupational Therapy
  therapeutic_modality: BEHAVIORAL
  target_phenotypes:
  - preferred_term: Flexion contracture of finger
    term:
      id: HP:0012785
      label: Flexion contracture of finger
  - preferred_term: Limited wrist movement
    term:
      id: HP:0006248
      label: Limited wrist movement
  notes: >-
    Curated as supportive standard of care on the same basis as Hearing
    Rehabilitation. No publication reports hand-therapy or orthopedic outcomes in
    a molecularly confirmed CDHS patient, so no evidence item is attached rather
    than citing a source that does not make the claim.
- name: Symptomatic Pharmacotherapy for Pulmonary Hypertension
  description: >-
    In the single reported CDHS patient with an unrepaired patent ductus arteriosus
    and established severe pulmonary hypertension, surgical closure was judged
    non-viable and management was purely symptomatic: furosemide, bosentan,
    enalapril and sildenafil. The treating team was explicit that this regimen was
    palliative rather than curative, and framed the outcome as a consequence of
    diagnostic delay rather than an inevitable disease course.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: furosemide
      term:
        id: CHEBI:47426
        label: furosemide
    - preferred_term: bosentan
      term:
        id: CHEBI:51450
        label: bosentan
    - preferred_term: enalapril
      term:
        id: CHEBI:4784
        label: enalapril
    - preferred_term: sildenafil
      term:
        id: CHEBI:9139
        label: sildenafil
  therapeutic_modality: SMALL_MOLECULE
  target_phenotypes:
  - preferred_term: Pulmonary arterial hypertension
    term:
      id: HP:0002092
      label: Pulmonary arterial hypertension
  evidence:
  - reference: PMID:39850491
    reference_title: "Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms and lack of holistic care."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      symptomatic treatment was prescribed, which included a loop diuretic
      (furosemide), a dual endothelin receptor antagonist
    explanation: >-
      Documents the specific agents used for the cardiopulmonary complication.
  - reference: PMID:39850491
    reference_title: "Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms and lack of holistic care."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These medications aim to manage symptoms rather than provide curative
      treatment
    explanation: >-
      States explicitly that the regimen is palliative, not disease-modifying.
- name: Genetic Counseling
  description: >-
    Autosomal dominant inheritance carries a 50% transmission risk to the offspring
    of an affected individual, as realized in the founding family where an affected
    mother had two affected children. Identification of the familial PAX3 variant
    enables predictive and reproductive testing.
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:14556253
    reference_title: Craniofacial-deafness-hand syndrome revisited.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The family had another child, a son, two years after the birth of the index
      case that had the exact manifestations as his mother and sister.
    explanation: >-
      Documents recurrence in a second child of an affected parent, the concrete
      basis for the recurrence-risk counseling.
- name: Multidisciplinary Surveillance
  description: >-
    Coordinated evaluation across genetics, audiology, cardiology and orthopedics
    at the time of diagnosis. The 2024 case report is essentially an argument for
    this: a heart murmur detected in infancy went unfollowed, the genetic diagnosis
    came years after presentation, and by the time the ductus arteriosus was
    characterized the accompanying pulmonary hypertension had made repair
    impossible. On the strength of a single case the cardiac-screening
    recommendation is provisional, but it is low-cost and the counterfactual harm
    is well documented.
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:39850491
    reference_title: "Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms and lack of holistic care."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      It also highlights the need for multidisciplinary collaboration and a
      holistic care model to improve patient outcomes.
    explanation: >-
      States the authors' central management recommendation.
  - reference: PMID:39850491
    reference_title: "Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms and lack of holistic care."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Considering the presence of pulmonary hypertension, the cardiologist
      determined that surgical repair of the PDA was not a viable option for the
      patient.
    explanation: >-
      Documents the concrete harm of delayed cardiac assessment that motivates
      surveillance.
differential_diagnoses:
- name: PAX3-Related Waardenburg Syndrome
  disease_term:
    preferred_term: Waardenburg syndrome
    term:
      id: MONDO:0018094
      label: Waardenburg syndrome
  description: >-
    The principal differential, and allelic at the same locus. Waardenburg syndrome
    type 1 shares sensorineural hearing loss, dystopia canthorum and a broad nasal
    bridge; type 3 (Klein-Waardenburg) adds upper-limb musculoskeletal
    abnormalities that can closely mimic the CDHS hand phenotype, and is caused by
    a different substitution at the very codon mutated in CDHS.
  distinguishing_features:
  - >-
    CDHS shows absent or hypoplastic nasal bones and a hypoplastic ulnar styloid
    over a normal calvarium, an imaging combination not seen in Waardenburg
    syndrome.
  - >-
    The founding CDHS family lacked the pigmentary stigmata (white forelock,
    heterochromia iridis, skin depigmentation) that characterize Waardenburg
    syndrome.
  - >-
    CDHS alleles are paired-domain missense substitutions, whereas most
    Waardenburg syndrome type 1 alleles are loss-of-function.
  evidence:
  - reference: PMID:18553554
    reference_title: "Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The imaging findings and distinct facial features was felt to distinguish
      CDHS from WS type 3.
    explanation: >-
      States the basis on which CDHS is separated from Waardenburg syndrome type
      3.
  - reference: PMID:8447316
    reference_title: "Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Both mutations were in the highly conserved paired domain of the human PAX3
      gene and are similar to other mutations that cause WS.
    explanation: >-
      Establishes that Waardenburg syndrome types 1 and 3 also arise from
      paired-domain PAX3 mutations, which is why the differential turns on the
      specific substitution and the imaging phenotype rather than on the domain
      alone.
- name: PAX3-negative craniofacial-deafness spectrum
  description: >-
    A 37-year-old woman with congenital sensorineural hearing loss, dystopia
    canthorum, a flat facial profile, ulnar deviation with digit contractures and
    fifth-finger clinodactyly — features overlapping both CDHS and Waardenburg
    syndrome type 3 — had no mutation in any PAX3 coding exon or splice boundary,
    with whole-gene deletion excluded by SNP heterozygosity. Craniofacial CT showed
    markedly hypoplastic-to-aplastic paranasal sinuses, underdeveloped mastoids and
    small cochleae with only 1.5 turns, findings not previously associated with
    Waardenburg syndrome. This case raises the possibility of locus heterogeneity
    within the CDHS-like phenotype.
  distinguishing_features:
  - >-
    Normal hand and wrist radiographs and normal nasal bones on CT — the two
    radiographic features that define CDHS.
  - >-
    Paranasal sinus, mastoid and cochlear anomalies not described in CDHS.
  - >-
    No detectable PAX3 coding or splice-site lesion, with whole-gene deletion
    excluded.
  evidence:
  - reference: PMID:18553554
    reference_title: "Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here we describe a woman who shares some, but not all features of WS type 3
      and CDHS, and who also has abnormal cranial bones. All sinuses were
      hypoplastic, and the cochlea were small. No sequence alteration in PAX3 was
      found.
    explanation: >-
      Documents a CDHS-overlapping phenotype without a PAX3 coding lesion.
  - reference: PMID:18553554
    reference_title: "Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These observations broaden the clinical range of WS and suggest there may be
      genetic heterogeneity even within the CDHS subtype.
    explanation: >-
      States the locus-heterogeneity hypothesis for the CDHS-like phenotype.
animal_models:
- species: Mus musculus
  genotype: Pax3 splotch (Sp) mutant
  description: >-
    The splotch mouse carries a spontaneous intron 3 splice-acceptor mutation in
    Pax-3 that generates four aberrantly spliced transcripts, none expected to
    yield functional protein. It is the classic Pax3 loss-of-function model and
    reproduces neural tube closure defects (exencephaly, spina bifida). A separate
    Pax3-Cre knock-in disruption model shows a foreshortened cochlea, malformed
    vestibular apparatus and loss of stria vascularis intermediate cells. Note the
    model-fidelity limits: splotch is a loss-of-function allele, whereas CDHS is
    caused by paired-domain missense substitutions proposed to be more damaging
    than simple loss of function, and no model carries a CDHS allele (N47K or
    T31P) or reproduces the full human triad.
  genes:
  - preferred_term: PAX3
    term:
      id: hgnc:8617
      label: PAX3
  evidence:
  - reference: PMID:8421686
    reference_title: A mutation within intron 3 of the Pax-3 gene produces aberrantly spliced mRNA transcripts in the splotch (Sp) mouse mutant.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      These aberrantly spliced mRNA transcripts are not expected to result in
      functional Pax-3 proteins and are thus responsible for the phenotype
      observed in the Sp mouse mutant.
    explanation: >-
      Establishes splotch as a Pax3 loss-of-function model.
  - reference: PMID:38278860
    reference_title: Loss of Pax3 causes reduction of melanocytes in the developing mouse cochlea.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      we found that Pax3 deficiency causes foreshortened cochlea, malformed
      vestibular apparatus, and neural tube defects
    explanation: >-
      Documents the inner-ear phenotype of murine Pax3 disruption, the closest
      available model support for the CDHS deafness mechanism.
discussions:
- discussion_id: cdhs_pax3_null_vs_missense_model_fidelity
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  prompt: >-
    Does murine Pax3 loss of function model the CDHS craniofacial phenotype, given
    that the splotch mouse is dominated by neural tube closure defects while the
    human paired-domain missense phenotype is dominated by midfacial skeletal
    hypoplasia with no reported neural tube defect?
  rationale: >-
    Every mechanistic claim about CDHS craniofacial development is extrapolated
    from Pax3 loss-of-function models, but the direction of the mismatch is
    substantive rather than cosmetic. The murine models are null or
    severely-hypomorphic alleles whose signature phenotype is exencephaly and
    spina bifida; the human CDHS alleles are paired-domain missense substitutions
    that the founding report proposed to be MORE damaging than the
    loss-of-function alleles causing Waardenburg syndrome type 1, and CDHS
    patients have not been reported with neural tube defects. A null-allele model
    therefore cannot test the allele-class hypothesis that defines CDHS, and its
    craniofacial readout cannot be assumed to correspond to the human midfacial
    phenotype. The cochlear melanocyte arm of the mechanism is on firmer ground
    because the murine phenotype (loss of stria vascularis intermediate cells)
    maps directly onto the shared human feature of sensorineural hearing loss.
  attaches_to:
  - pathophysiology#Cranial Neural Crest Patterning Failure
  - pathophysiology#Craniofacial Skeletal Hypoplasia
  evidence:
  - reference: PMID:8421686
    reference_title: A mutation within intron 3 of the Pax-3 gene produces aberrantly spliced mRNA transcripts in the splotch (Sp) mouse mutant.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      The splotch (Sp) mouse mutant displays defects in neural tube closure in
      the form of exencephaly and spina bifida.
    explanation: >-
      Establishes that the murine model's signature phenotype is a neural tube
      closure defect, which is not a reported feature of human CDHS — the
      observation that motivates this mismatch.
  - reference: PMID:8664898
    reference_title: Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      appears to have a more drastic effect on the phenotype than missense,
      frameshift and deletion mutations of PAX3 that cause Waardenburg syndrome
      type 1
    explanation: >-
      States the allele-class hypothesis that a loss-of-function model cannot
      test, since the CDHS allele is proposed to act differently from the
      loss-of-function alleles the murine models carry.
  proposed_experiments:
  - experiment_id: exp_cdhs_pax3_n47k_knockin_vs_null
    name: Pax3 N47K knock-in versus null allele phenotype comparison
    description: >-
      Generate a knock-in mouse carrying the orthologous Pax3 N47K substitution
      and compare its craniofacial, otic and limb phenotypes against a Pax3 null
      allele on the same genetic background, to test directly whether the CDHS
      allele class acts by a mechanism distinct from haploinsufficiency.
  - experiment_id: exp_cdhs_pax3_allele_biochemistry
    name: Comparative DNA-binding and transactivation assay of CDHS versus Waardenburg alleles
    description: >-
      Assay DNA binding, target-gene occupancy and transactivation of PAX3 N47K
      and T31P against wild-type protein and against the Waardenburg-associated
      N47H protein, to determine whether the CDHS alleles are hypomorphic,
      dominant-negative or neomorphic.
- discussion_id: cdhs_hand_phenotype_mechanism_unexplained
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    By what mechanism does a PAX3 paired-domain missense allele produce the hand
    phenotype of CDHS — and specifically, does the somitic/limb-muscle route
    account for the skeletal findings (hypoplastic ulnar styloid) as well as the
    contractural ones (ulnar deviation, digit flexion contractures)?
  rationale: >-
    The hand is one third of the cardinal triad and carries three diagnostic
    phenotypes, yet it is the least mechanistically supported arm of the entry.
    Two things are worth separating. First, the lineage question is settled
    enough to model: the wrist and limb musculature are somite and lateral-plate
    derivatives, so they cannot descend from the cranial neural crest node, and
    PAX3's dermomyotome/limb-muscle role supplies a plausible separate branch —
    which is why the Somitic and Limb Musculoskeletal Patterning Disturbance node
    exists at HYPOTHETICAL confidence. Second, and still open: that myogenic
    route is a natural explanation for deviation and contracture, but not for
    hypoplasia of a bone. The hypoplastic ulnar styloid therefore has no incoming
    causal edge in this entry, deliberately, rather than being attached to a node
    that does not explain it. No limb or muscle tissue from a CDHS patient has
    ever been examined, and no murine model carries a CDHS allele, so both halves
    of the question are open on human evidence.
  attaches_to:
  - pathophysiology#Somitic and Limb Musculoskeletal Patterning Disturbance
  - pathophysiology#Altered Paired-Domain DNA Recognition
  evidence:
  - reference: PMID:7744814
    reference_title: Pax3 inhibits myogenic differentiation of cultured myoblast cells.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Mutations in Pax-3 account for the mouse mutant Splotch which develops
      without limb musculature.
    explanation: >-
      The strongest available support for a PAX3-dependent limb mechanism, and
      simultaneously the measure of the gap: it is a murine null allele producing
      absent musculature, not a human missense allele producing deviation,
      contracture and a hypoplastic styloid process.
  proposed_experiments:
  - experiment_id: exp_cdhs_limb_imaging_and_muscle_phenotyping
    name: Systematic upper-limb imaging and muscle phenotyping in ascertained CDHS patients
    description: >-
      Combine hand/wrist radiography with MRI or ultrasound of the forearm and
      intrinsic hand musculature in any ascertained CDHS patient, to establish
      whether the deformity is primarily myogenic (muscle hypoplasia or imbalance
      with secondary joint deformity) or primarily skeletal (a dysplastic ulnar
      styloid and carpus), which the plain radiographs reported to date cannot
      distinguish.
  - experiment_id: exp_cdhs_limb_phenotype_in_n47k_knockin
    name: Limb phenotyping of a Pax3 N47K knock-in allele
    description: >-
      Phenotype forelimb musculature and the distal skeleton in the Pax3 N47K
      knock-in proposed under the model-fidelity discussion, comparing against a
      Pax3 null allele, to test whether the CDHS allele class produces the
      human-like deviation-and-contracture pattern rather than the absent-muscle
      pattern of the null.
- discussion_id: cdhs_cardiovascular_association_single_case
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Is the cardiovascular involvement reported in one CDHS patient (patent ductus
    arteriosus with secondary pulmonary hypertension) a genuine part of the CDHS
    phenotypic spectrum, or a coincidental finding in a single patient?
  rationale: >-
    The association rests on one 21-year-old patient with a novel PAX3 p.Thr31Pro
    variant. The argument for causality is reasonable — more than 100
    congenital-heart-disease genes were screened without an alternative
    explanation, and PAX3 is expressed in cardiac neural crest, whose derivatives
    build the outflow tract — but it remains a single unreplicated case, and no
    cardiac assessment was reported for the founding family. Resolving this
    matters practically, because it determines whether echocardiography belongs in
    the baseline evaluation of every newly diagnosed patient.
  attaches_to:
  - pathophysiology#Cranial Neural Crest Patterning Failure
  evidence:
  - reference: PMID:39850491
    reference_title: "Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms and lack of holistic care."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The genetic findings provided a definitive diagnosis of
      Craniofacial-Deafness-Hand Syndrome, an extremely rare autosomal dominant
      condition, but found no variants that explain the patient's cardiac
      phenotype.
    explanation: >-
      The sole source of the cardiovascular association. Marked PARTIAL because
      it establishes only that no alternative genetic explanation was found in
      one patient, which is suggestive rather than confirmatory.
  - reference: PMID:15226254
    reference_title: "Cardiac neural crest of the mouse embryo: axial level of origin, migratory pathway and cell autonomy of the splotch (Sp2H) mutant effect."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Embryos homozygous for the Sp2H mutation show delayed onset of cardiac
      neural crest emigration
    explanation: >-
      Supplies the biological plausibility for the association: murine Pax3 loss
      perturbs cardiac neural crest, whose derivatives build the outflow tract.
      INDIRECT because a mouse null allele cannot establish that a human CDHS
      missense allele causes patent ductus arteriosus.
  proposed_experiments:
  - experiment_id: exp_cdhs_systematic_echocardiography
    name: Systematic echocardiographic screening of ascertained CDHS patients
    description: >-
      Perform echocardiography on surviving members of the founding N47K family
      and on any newly ascertained CDHS patient, and report the result whether
      positive or negative, so that the denominator for the cardiovascular
      association becomes interpretable.
notes: >-
  NEC preflight (Named Entity Confusion): the target entity was confirmed against
  MONDO:0007395 with OAK before curation. The MONDO record gives gene PAX3
  (HGNC:8617), OMIM:122880 and Orphanet:1529; the causal gene named throughout the
  deep-research report and every primary source cited here is PAX3, and the OMIM
  number asserted in the sources (MIM 122880) matches the MONDO xref. The main NEC
  hazard for this disease is its close allelic relative, Waardenburg syndrome
  (MONDO:0018094), which shares the gene; sources were checked individually and
  none described the wrong entity.

  GeneReviews baseline: NO GeneReviews chapter exists for CDHS. A PubMed search
  ("craniofacial-deafness-hand GeneReviews[All Fields]") returns zero records. The
  nearest chapter is Waardenburg Syndrome Type I (PMID:20301703), which covers a
  different, allelic disease and is therefore not cited here as a phenotype
  baseline. The phenotype baseline for this entry is instead the primary
  literature: the original description (PMID:6859126), the molecular
  characterization (PMID:8664898), and the 20-year follow-up (PMID:14556253).

  Relationship to the existing PAX3_Waardenburg_Spectrum entry: that entry
  deliberately records CDHS as an allelic note and a differential diagnosis rather
  than as a Waardenburg subtype, on the grounds that ClinGen scopes CDHS out of
  the PAX3-Waardenburg gene-disease validity assertion. This entry is the
  standalone counterpart that note anticipated. The two should stay reciprocally
  linked and must not be merged.

  Evidence ceiling: this is one of the smallest evidence bases in the knowledge
  base. Nine records match "craniofacial-deafness-hand syndrome" in PubMed, of
  which four concern the disease directly (PMID:6859126, PMID:8664898,
  PMID:14556253, PMID:39850491), one is a Japanese-language review
  (PMID:11462543), and one describes a PAX3-negative overlapping phenotype
  (PMID:18553554). Essentially all clinical detail derives from three affected
  individuals across two generations of one family, plus two later single
  patients. Frequency bands marked VERY_FREQUENT therefore mean "present in every
  affected individual of the only well-characterized family", not a
  cohort-derived percentage, and no penetrance, sex-ratio or survival statistic
  can be responsibly stated.

  Generation count — a discrepancy between two cited sources, resolved in favour
  of the primary one. PMID:18553554 (Gad 2008) describes CDHS as "described in a
  three-generation family that was evaluated several times over a period of 24
  years". That is incorrect. The clinicians who described and followed the family
  report two generations: PMID:6859126 reports "a mother and her infant daughter",
  and PMID:14556253 states "three affected family members in two generations"
  after a son was born two years after the index case. This entry therefore says
  three affected individuals across two generations throughout. The point is
  recorded here because Gad 2008 is cited elsewhere in this entry and a future
  curator reading it could reasonably reintroduce the error.

  Features deliberately NOT curated as CDHS phenotypes: microcephaly, short
  stature, kyphoscoliosis, pectus carinatum, shoulder-girdle hypoplasia, nail
  clubbing, cubitus valgus, an iris hypopigmented lesion and undernutrition are
  all reported in the single p.Thr31Pro patient (PMID:39850491) only, were absent
  from the founding family's description, and several are plausibly secondary to
  that patient's chronic uncorrected cardiopulmonary disease. Paranasal sinus
  hypoplasia, mastoid underdevelopment and a Mondini-type small cochlea are
  reported only in the PAX3-negative patient (PMID:18553554) and are curated under
  differential_diagnoses rather than as CDHS features. Adding any of these as
  disease-level phenotypes would overstate a one-patient observation as a syndrome
  feature.

  Deep research: falcon (Edison) was attempted first per the default provider
  policy but the API returned HTTP 402 Payment Required, so the run could not
  execute. Two providers were used instead: claude_code
  (research/Craniofacial-Deafness-Hand_Syndrome-deep-research-claude_code.md) and
  openscientist
  (research/Craniofacial-Deafness-Hand_Syndrome-deep-research-openscientist.md).
  They agree on the gene, the allele class, the codon-47 N47K/N47H
  genotype-phenotype contrast, the case inventory and the identifier set. Every
  PMID, snippet and ontology term in this entry was independently re-derived from
  the cached primary sources and OAK rather than copied from either report.

  Two provider errors were caught and are recorded so they are not reintroduced.
  (1) The claude_code report gave CHEBI:51068 for bosentan; that ID is actually
  "miotic", and the OAK-verified bosentan term CHEBI:51450 is used instead.
  (2) The openscientist report states that CDHS lacks dystopia canthorum ("without
  the pigmentary anomalies ... or dystopia canthorum that typify Waardenburg").
  That is wrong: PMID:14556253 describes the founding family as having "a
  phenotype of midfacial anomalies and dystopia canthorum resembling Waardenburg
  syndrome", and PMID:18553554 lists "hypertelorism and dystopia canthorum" among
  the CDHS clinical features. Dystopia canthorum is therefore curated here as a
  present phenotype. It is the pigmentary stigmata, not dystopia canthorum, that
  CDHS characteristically lacks.
  (3) The claude_code report gives the N47K allele as "c.141T>A". That is
  incompatible with the source, which reports "the C-to-G transversion in codon
  47" (PMID:8664898). The cDNA-level notation was therefore not curated; the
  variant is recorded at the protein level (p.Asn47Lys), with the transversion
  described in the evidence snippet.
  (4) The claude_code report asserts that Splotch mice have "no facial
  phenotype", attributed loosely to "PMID:8421686 and related literature". That
  PMID reports the splicing mutation and neural tube defects and makes no such
  claim, so the assertion was not curated. The model-fidelity concern it gestures
  at is real, but is stated differently in this entry — as a neural-tube-dominant
  murine phenotype versus a midface-dominant human one, with the allele class as
  the underlying difference — in the
  cdhs_pax3_null_vs_missense_model_fidelity discussion.

  HPO disease-annotation phenotypes NOT curated, and why. The openscientist
  report reproduces the HPO/Monarch disease annotation for MONDO:0007395 (28
  disease-phenotype associations). Four terms it lists as "Very frequent" are
  absent from this entry: Blepharophimosis (HP:0000581), Narrow face
  (HP:0000275), Lacrimal duct atresia (HP:0000564) and Aplasia/Hypoplasia
  involving the nose (HP:0009924). Two are near-duplicates of terms already
  curated at a different level of the HPO hierarchy (blepharophimosis versus the
  curated Short palpebral fissure HP:0012745; the nose term versus the curated
  Short nose and Narrow naris). Lacrimal duct atresia and Narrow face are
  genuinely distinct findings and would be real additions.

  They are omitted for one reason: the strings "lacrimal", "blepharophimosis" and
  "narrow face" appear in NONE of the cached references for this disease. The HPO
  annotation for CDHS derives from the OMIM clinical synopsis of the Sommer 1983
  full text, and PMID:6859126 is abstract-only in references_cache (718
  characters), so there is no cached body to quote. Adding these phenotypes would
  require an evidence item with either no snippet or a fabricated one, both of
  which the project SOP forbids. Resolving this needs either the Sommer 1983 full
  text in the cache, or a project-level decision on whether HPO disease
  annotations (HPOA) may serve as a citable evidence source in their own right —
  a schema/policy question beyond a single-disorder entry.

  Orphanet: ORPHA:1529 exists for this disease but is not in references_cache,
  because `just refresh-orphadata` currently fails on a sha256 mismatch against
  the pinned data/orphadata/MANIFEST.yaml and re-pinning would invalidate all
  existing ORPHA cache files. Once the manifest is refreshed repo-wide, the
  Orphanet HPO frequency table for ORPHA:1529 would be the best available source
  for phenotype frequencies.
references:
- reference: PMID:6859126
  title: "Previously undescribed syndrome of craniofacial, hand anomalies, and sensorineural deafness."
- reference: PMID:8664898
  title: "Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome."
- reference: PMID:14556253
  title: "Craniofacial-deafness-hand syndrome revisited."
- reference: PMID:18553554
  title: "Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome?"
- reference: PMID:24839464
  title: "PAX3 gene deletion detected by microarray analysis in a girl with hearing loss."
- reference: PMID:39850491
  title: "Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms and lack of holistic care."
📚

References & Deep Research

References

6
PMID:6859126
Previously undescribed syndrome of craniofacial, hand anomalies, and sensorineural deafness.
No top-level findings curated for this source.
PMID:8664898
Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome.
No top-level findings curated for this source.
PMID:14556253
Craniofacial-deafness-hand syndrome revisited.
No top-level findings curated for this source.
PMID:18553554
Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome?
No top-level findings curated for this source.
PMID:24839464
PAX3 gene deletion detected by microarray analysis in a girl with hearing loss.
No top-level findings curated for this source.
PMID:39850491
Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms and lack of holistic care.
No top-level findings curated for this source.

Deep Research

2
Claude Code ▸
Craniofacial-Deafness-Hand Syndrome (CDHS): Comprehensive Research Report
claude-haiku-4-5-20251001, claude-sonnet-5 16 citations 2026-07-31T23:46:09.676853

Craniofacial-Deafness-Hand Syndrome (CDHS): Comprehensive Research Report

Note on ontology terms: HPO/GO/CL/UBERON/CHEBI/NCIT IDs below are provided as curatorial leads. Per this project's anti-hallucination policy, every term ID and label should be independently confirmed with OAK (runoak -i sqlite:obo:<ont> info <ID>) before being written into a KB entry — several are marked "verify" because I could not directly confirm the canonical label text against the ontology in this session.

1. Disease Information

Overview: Craniofacial-deafness-hand syndrome (CDHS) is an extremely rare autosomal dominant multiple-congenital-anomaly disorder combining (1) a distinctive craniofacial dysmorphism, (2) profound congenital sensorineural hearing loss, and (3) hand/wrist anomalies (ulnar deviation, camptodactyly/flexion contractures of digits 3–5). It is caused by heterozygous mutation of PAX3 (2q36.1) and is now understood as a severe allelic variant at the same locus responsible for Waardenburg syndrome types 1 and 3 (WS1/WS3) — "Constitutional mutations of PAX3 lead to Waardenburg syndrome (WS) or Craniofacial-deafness-hand (CFDS) syndrome" (per OMIM/PAX3 literature synthesis).

Key identifiers: | Resource | ID | |---|---| | OMIM (phenotype) | #122880 — CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS | | OMIM (gene) | *606597 — PAX3 | | Orphanet | ORPHA:1529 | | MedGen (NCBI) | C1852510 | | ICD-10 | Q87.0 (congenital malformation syndromes predominantly affecting facial appearance) — reported value, confirm against your ICD-10 coding source | | ICD-11 | LD2H.Y (reported) | | MONDO | Not confirmed in this session — a mapping likely exists (searchable via the OMIM/Orphanet xref); verify with runoak -i sqlite:obo:mondo before use | | HGNC (PAX3) | HGNC:8617 | | Gene location | 2q36.1 |

Synonyms: CDHS; craniofacial–deafness–hand syndrome; Sommer syndrome (informal, after the describing author). Note: MedGen groups PAX3-related concepts (CDHS, WS1, WS3) under a shared gene record — CDHS itself does not carry "WS1/WS3" as true clinical synonyms; it is a distinct, allelic phenotype, not a subtype label.

Evidence base: This is one of the rarest disorders in the medical literature — derived almost entirely from a handful of individual case/family reports (aggregated disease-level synthesis in OMIM/Orphanet/GeneReviews-adjacent resources is built directly from these same primary reports, not from registries or large cohorts).

2. Etiology

Disease causal factor: CDHS is a monogenic disorder. All confirmed and candidate cases are attributable to heterozygous, typically de novo or dominantly inherited, disruption of PAX3 — either a missense variant in the paired-domain DNA-binding region, or a genomic deletion encompassing the gene.

Genetic risk factors: - PAX3 missense mutation, paired domain, N47K (Asn47Lys): the founding CDHS family (PMID:8664898, Asher et al. 1996, Human Mutation). Quote: "a missense mutation (Asn47Lys) in the paired domain of PAX3" was found in "a family of three affected individuals with this syndrome, a mother and two children." The authors specifically noted that "substitution of a basic amino acid for asparagine at residue 47, conserved in all known murine Pax and human PAX genes, appears to have a more drastic effect on the phenotype than missense, frameshift and deletion mutations of PAX3 that cause Waardenburg syndrome type 1" — i.e., this particular paired-domain lesion is proposed as mechanistically more severe than typical WS1-causing alleles. - PAX3 missense variant, paired domain, T31P (p.Thr31Pro; c.A91C): a novel variant reported in a 2024/2025 case (PMID:39850491, Saenz Hinojosa et al., Frontiers in Genetics), also within the conserved paired-box (PB) domain, meeting ACMG pathogenic criteria (PS2, PM1, PM2, PM4, PP3, PP4). - ~862 kb de novo 2q36.1 deletion encompassing PAX3 (plus CCSC140 and part of SGPP2): reported in a 16-year-old girl with an intermediate WS1/CDHS phenotype (PMID:24839464, Drozniewska et al. 2014, Molecular Cytogenetics). This supports haploinsufficiency (loss-of-function/dosage) as a viable CDHS mechanism, not only missense gain-of-severity. - Negative-finding case: a 37-year-old woman with a partially overlapping phenotype (hearing loss + some craniofacial features, but normal hand films/nasal bones and a Mondini cochlear malformation) had no PAX3 coding mutation found on full gene sequencing (PMID:18553554, PMC2533638) — heterozygosity for a PAX3 SNP excluded whole-gene deletion, but a partial/regulatory deletion could not be ruled out. This case is best framed as an unresolved WS-spectrum variant rather than confirmed CDHS.

Environmental / infectious risk factors: None established or reported. CDHS is a purely monogenic, developmental (neural-crest patterning) disorder with no known environmental, occupational, dietary, or infectious contribution.

Protective factors: None reported (genetic or environmental) — expected for an ultra-rare fully penetrant dominant disorder with no population-scale data available.

Gene–environment interaction: Not applicable / not studied given the extreme rarity and small number of reported cases.

3. Phenotypes

CDHS phenotypes cluster into three domains — craniofacial, otologic, and hand/limb — with an emerging fourth (cardiovascular) domain from the most recent case report.

Craniofacial features

  • Flat/depressed facial profile with a normal calvarium (distinguishing radiologically from other craniofacial syndromes)
  • Hypertelorism — suggested term: HP:0000316 Hypertelorism (verify)
  • Small, downslanting palpebral fissures with an "antimongoloid" slant — suggested term: HP:0000494 Downslanted palpebral fissures (verify)
  • Depressed/absent nasal bridge, "button tip," slit-like nares, hypoplastic/absent nasal bones (radiographically absent or small nasal bones) — suggested terms: HP:0005280 Depressed nasal bridge; HP:0000463 (verify label) for anteverted/slit nares
  • Small, "pursed" mouth
  • Maxillary hypoplasia, malar flattening
  • Frontal bossing (variably reported)
  • Microcephaly (reported in the 2024 case; head circumference 50 cm at age 21 — not part of the original description, so may reflect phenotypic variability or an independent finding)

Otologic / auditory

  • Profound (or severe) bilateral sensorineural hearing loss, congenital/present from birth in the classic family; onset at age 8 in the 2024 case (moderate–severe right, profound left) — suggested term: HP:0000407 Sensorineural hearing impairment (verify)
  • Frequency: reported in 100% of confirmed cases to date (small N, so this is a qualitative "always present" observation, not a population-derived percentage)
  • Associated inner-ear structural anomaly reported in a WS-spectrum case: Mondini cochlear deformity (1.5 vs normal 2.5 turns) (PMID:18553554) — not established as core CDHS pathology, but illustrative of the PAX3/otic-capsule connection

Hand / limb

  • Ulnar deviation of the fingers/hand
  • Camptodactyly / flexion contractures of digits 3, 4, and 5
  • Limited wrist movement; hypoplastic ulnar styloid (radiographic)
  • Clinodactyly of the 5th finger; in the 2024 case, additional findings of nail clubbing, increased DIP-joint prominence of digit 5, and increased PIP-joint prominence of digits 2–3 bilaterally
  • Suggested terms: HP:0009465 (verify) Ulnar deviation of the hand/fingers; HP:0012385 Camptodactyly

Other reported (variable / emerging)

  • Short stature (158 cm at 21 y in the 2024 case)
  • Thoracic asymmetry, shoulder-girdle hypoplasia, kyphoscoliosis, pectus carinatum, bilateral cubitus valgus
  • Iris pigmentary anomaly (hypopigmented iris lesion) — note this overlaps with the WS pigmentary spectrum even though CDHS is nominally distinguished from WS by lacking classic pigmentary stigmata (white forelock, heterochromia) in the founding family
  • Patent ductus arteriosus, cardiomegaly, severe pulmonary hypertension, valvular insufficiency — first reported cardiovascular phenotype in CDHS (PMID:39850491); authors note PAX3's known role in cardiac neural crest and cite the Splotch mouse's persistent-truncus-arteriosus/outflow-tract phenotypes as mechanistic precedent
  • Undernutrition (secondary, reported once)

Age of onset: Congenital for the craniofacial and hand features; hearing loss present from birth in the original family, but documented as later-onset (age 8) in the 2024 case — suggesting a broader age range than initially appreciated.

Severity/progression: Described as stable across a 20-year longitudinal follow-up of the original family (PMID:14556253) — "the extended follow-up period allowed observation of phenotype stability across childhood into adulthood." No degenerative/progressive component is described for the core triad; the cardiovascular complication in the 2024 case reflects a previously undiagnosed structural cardiac lesion (PDA) that became symptomatic with age, not a progressive dysplasia.

Quality of life impact: Profound congenital deafness is the dominant driver of QoL impact (communication/speech/social development), compounded in the 2024 case by delayed diagnosis, fragmented specialty care, and untreated PDA/pulmonary hypertension leading to significant cardiopulmonary morbidity by young adulthood. No formal EQ-5D/SF-36/PROMIS data exist for this disorder given its rarity.

4. Genetic / Molecular Information

Causal gene: PAX3 (paired box 3), HGNC:8617, OMIM *606597, chromosome 2q36.1.

Variants identified in CDHS to date: | Variant | Type | Domain | Case | PMID | |---|---|---|---|---| | c.141T>A / N47K (Asn47Lys) | Missense | Paired domain (exon 2) | Founding family (mother + 2 children), 1983/1996/2003 | 8664898, 14556253, 6859126 | | c.A91C / p.T31P (Thr31Pro) | Missense | Paired box (PB) domain, exon 2 | 21-year-old Ecuadorian male, 2024 | 39850491 | | ~862 kb deletion at 2q36.1 (whole-gene) | Deletion (de novo, CNV) | Whole gene + CCSC140 + partial SGPP2 | 16-year-old girl, intermediate WS1/CDHS phenotype | 24839464 | | Full PAX3 coding sequence — no mutation found | N/A (negative) | — | 37-year-old woman, partial phenotype | 18553554 |

Variant classification (ACMG/AMP, 2024 case, PMID:39850491): Pathogenic — criteria met: PS2 (de novo, no family history), PM1 (well-established functional domain), PM2 (absent from gnomAD/population databases), PM4 (evolutionarily conserved residue), PP3 (concordant in-silico damage predictions — SIFT 0.015 damaging, PolyPhen-2 1.0 deleterious, MutationTaster 1 disease-causing, PROVEAN −3.13 deleterious, FATHMM −3.43 deleterious), PP4 (phenotype specificity).

Allele frequency: Absent from gnomAD / population databases for both missense variants (expected given the extreme rarity and severity of the phenotype).

Somatic vs. germline: All reported variants are germline — either transmitted (autosomal dominant, the founding family) or de novo (2024 case; 2014 deletion case).

Functional consequence / mechanism: PAX3 encodes a paired-box/homeodomain transcription factor with: - An N-terminal paired domain (PD) — two subdomains, PAI and RED, each with helix-turn-helix motifs for sequence-specific DNA binding - A central homeodomain (HD) — three helix-turn-helix subdomains, helix III mediating DNA recognition - A linker octapeptide motif (HSIDGILS) that recruits transcriptional corepressors - A C-terminal proline/serine-rich transactivation domain (TAD) - An N-terminal transcriptional repression domain (TRD), function less well characterized

Both confirmed CDHS missense variants (N47K, T31P) map to the paired domain, the primary DNA-recognition module — consistent with a model in which specific, severe disruption of paired-domain DNA binding produces a more drastic phenotype than the broader spectrum of PAX3 lesions (missense/frameshift/deletion, including whole-gene loss) that typically produce the milder WS1/WS3 phenotype. The 2014 whole-gene-deletion case, however, shows that simple haploinsufficiency can also produce an intermediate/CDHS-leaning phenotype, so the genotype–phenotype correlation is not absolute (as also concluded broadly for PAX3: "little correlation between genotype and phenotype; deletions of the entire PAX3 gene result in phenotypes indistinguishable from those associated with single-base substitutions").

Modifier genes: None identified specific to CDHS. (In the 2024 cardiovascular case, extensive sequencing of >100 congenital-heart-disease genes found no additional variant explaining the cardiac phenotype, implicating PAX3 itself in the cardiac finding.)

Epigenetics / chromosomal abnormalities: No CDHS-specific epigenetic studies exist. The 2q36.1 deletion case is the only chromosomal-scale lesion reported; standard karyotype is otherwise normal in described cases.

5. Environmental Information

No environmental, lifestyle, occupational, dietary, or infectious contributing factors have been identified or proposed for CDHS in the literature — consistent with its status as a fully penetrant, single-gene developmental disorder.

6. Mechanism / Pathophysiology

Causal chain (proposed): 1. Trigger: Heterozygous PAX3 lesion disrupting paired-domain DNA binding (missense) or reducing gene dosage (deletion) 2. Molecular: Impaired/altered PAX3 transcription-factor activity — loss of normal cooperative transactivation of downstream targets (MITF with SOX10; WNT1, CXCR4, c-RET in neural crest; MYOD/MYF5/DMRT2 in myogenic precursors) 3. Cellular: Defective neural crest cell induction, survival, migration, and differentiation — PAX3 "orchestrates neural crest-specific gene expression" and promotes neural-crest-cell survival/stress resistance 4. Tissue: Disrupted derivatives of the cranial and cardiac neural crest — craniofacial skeleton (absent/hypoplastic nasal bones, midface hypoplasia), inner ear/cochlear melanocytes and structure (sensorineural deafness — PAX3 loss "causes reduction of melanocytes in the developing mouse cochlea," PMC/Nature 2024), limb/hand mesenchyme patterning (ulnar deviation, camptodactyly), and cardiac outflow-tract neural crest (PDA, in the 2024 case) 5. Organism: The clinical triad (craniofacial dysmorphism + deafness + hand anomalies), with cardiovascular involvement as an emerging, possibly underrecognized, fourth domain

Molecular pathways: PAX3–SOX10–MITF axis (melanocyte specification/melanogenesis); PAX3-driven WNT1/CXCR4/c-RET (neural crest migration); PAX3–MYOD/MYF5 (myogenic specification, less relevant to CDHS's core phenotype but part of PAX3 biology generally).

Cell types involved: Cranial neural crest cells, otic/cochlear melanocytes (intermediate cell population of the stria vascularis), craniofacial mesenchyme/osteogenic precursors, cardiac neural crest cells (outflow tract). Suggested CL terms (verify with OAK): CL:0000333 (neural crest cell), CL:0000148 (melanocyte).

Biological processes: Neural crest cell migration, craniofacial skeletal morphogenesis, inner ear development, cochlear melanocyte differentiation, cardiac outflow tract morphogenesis. Suggested GO terms (verify): GO:0014032 (neural crest cell development), GO:0042475 (odontogenesis of dentin-containing tooth — not relevant, omit), GO:0060384 (innervation — not directly relevant); more precisely GO:0001755 (neural crest cell migration), GO:0043010 (camera-type eye development — not relevant). Given the specificity needed, curators should search GO directly for "neural crest cell migration," "inner ear morphogenesis," and "cardiac neural crest cell migration."

Protein dysfunction: Altered DNA-binding specificity/affinity of the paired domain (missense variants) or simple loss of one functional gene copy (deletion) — both converge on reduced/altered PAX3 transcriptional output during a narrow embryonic window of neural crest patterning.

Model-system evidence supporting mechanism (not confirmed in CDHS patients directly — flag as model-organism-derived): - Splotch (Sp) mouse — Pax3 loss-of-function model: dorsal neural tube closure defects (spina bifida, exencephaly), and (per the 2024 CDHS case report's discussion) cardiac neural crest phenotypes including myocardial dysfunction, persistent truncus arteriosus, and outflow-tract malalignment — cited as mechanistic precedent for the patient's PDA/pulmonary hypertension, though the Splotch mouse itself reportedly has no facial phenotype (PMID:8421686 and related Pax3/vertebrate-development literature), a notable human-model mismatch: PAX3 loss clearly produces craniofacial dysmorphism in humans (WS1/WS3/CDHS) but not in the mouse facial skeleton, indicating species-specific roles for Pax3 in facial neural crest patterning. - Mouse cochlea: Pax3 loss reduces melanocytes in the developing cochlea, supporting the deafness mechanism (Nature Scientific Reports, 2024).

Molecular profiling (transcriptomics/proteomics/etc.): No disease-specific -omics datasets exist for CDHS patients; all mechanistic inference is extrapolated from general PAX3 developmental biology and mouse models, not primary human multi-omics data on CDHS cases.

7. Anatomical Structures Affected

Organ/system level: - Craniofacial skeleton (nasal bones, maxilla, malar bones) — primary - Inner ear / cochlea (sensorineural hearing apparatus) — primary - Hand/wrist skeleton and soft tissue (ulna, carpal region, digits 3–5) — primary - Cardiovascular system (ductus arteriosus, pulmonary vasculature) — secondary/emerging, reported in one case - Ocular (iris pigmentation) — secondary, variably reported - Axial skeleton (kyphoscoliosis, pectus carinatum) — secondary, reported in one case

Tissue/cell level: Craniofacial neural-crest-derived bone and connective tissue; cochlear melanocytes/stria vascularis; limb mesenchyme; cardiac neural crest-derived outflow tract tissue.

Subcellular level: Nuclear (PAX3 is a nuclear transcription factor; its dysfunction is a nuclear/transcriptional-regulation defect, not an organelle-level pathology). Suggested GO Cellular Component term: GO:0005634 (nucleus).

Localization / laterality: Bilateral and generally symmetric involvement of ears, hands, and facial midline structures; no lateralization pattern reported. Suggested UBERON terms (verify): UBERON:0001691 (nasal bone/nose), UBERON:0001846 (cochlea), UBERON:0002389 (hand), UBERON:0001091 (ulna).

8. Temporal Development

  • Onset: Congenital for craniofacial and hand features; hearing loss present from birth in the founding family (later-recognized at age 8 in the 2024 case, possibly reflecting ascertainment/diagnostic delay rather than true later biological onset).
  • Onset pattern: Present at birth (structural anomalies); the cardiovascular complication in the 2024 case became clinically apparent (dyspnea) only in young adulthood (age 19), following an unaddressed infantile heart murmur — an important "critical period" lesson: early cardiac evaluation in infancy might have altered the outcome.
  • Progression: Craniofacial/hand phenotype is stable, non-progressive over a documented 20-year follow-up. The cardiac lesion (PDA + pulmonary hypertension), left untreated, followed the natural progressive course typical of uncorrected left-to-right shunts (Eisenmenger-type physiology by adulthood).
  • Disease course: Chronic, lifelong for the core triad; the cardiovascular complication in the one reported case became an unresectable/inoperable chronic condition due to delayed diagnosis.
  • Remission: Not applicable — structural/developmental anomalies do not remit.
  • Critical periods: Embryonic neural crest migration (roughly the first trimester) is the presumed critical window for the craniofacial/otic/cardiac neural crest anomalies; infancy is a critical window for hearing-loss detection/intervention and for cardiac murmur follow-up (as the 2024 case explicitly illustrates by its negative example).

9. Inheritance and Population

Epidemiology: Prevalence is reported as <1 in 1,000,000 (ultra-rare). The disorder has been "described in one family to date" in canonical references (the founding Sommer family), with subsequent isolated case reports (2008, 2014, 2024/2025) expanding the total documented cases to a handful worldwide. This is one of the rarest named Mendelian syndromes in the literature.

Inheritance pattern: Autosomal dominant. The founding family showed vertical transmission across two generations (affected mother → affected daughter and, two years later, an affected son — "identical manifestations across three family members spanning two generations"). Other reported cases (2014 deletion, 2024 missense) arose de novo.

Penetrance: Appears complete in the reported pedigree (all three affected family members show the full triad), though the total pedigree size is too small to estimate penetrance rigorously.

Expressivity: Some variability is evident across cases (e.g., presence/absence of cardiovascular involvement, variable craniofacial severity, variable hearing-loss onset age), consistent with variable expressivity typical of PAX3-spectrum disorders.

Genetic anticipation, germline mosaicism, founder effects, consanguinity: None reported/applicable — the very small number of families precludes meaningful assessment, and no consanguinity was noted in any reported case (parents in the 2024 case were unaffected and non-consanguineous; same for the 2014 and 2008 cases).

Carrier frequency: Not applicable (fully penetrant dominant disorder, not a recessive carrier state).

Population demographics: Reported cases span diverse ancestries (the founding family's ancestry is not emphasized in available sources; more recent cases include an Ecuadorian male). No geographic clustering, sex predilection or age-distribution pattern can be established from the very small case series (2 affected females and 2 affected males across all fully described cases, i.e., no clear sex bias but N is far too small to be meaningful).

10. Diagnostics

Clinical recognition: Diagnosis is currently based on the clinical triad (distinctive facial dysmorphism + congenital/early sensorineural deafness + hand anomalies), supported by radiographic findings (absent/hypoplastic nasal bones, normal calvarium, hypoplastic ulnar styloid, ulnar deviation of the hand) and then confirmed molecularly.

Laboratory/imaging tests: - Skull/facial radiography — absent or small nasal bones, normal calvarium, small maxilla - Hand/wrist radiography — ulnar deviation, hypoplastic ulnar styloid, flexion contractures - Audiometry / ABR — confirms severe-to-profound bilateral sensorineural hearing loss - Temporal bone CT — can reveal associated inner-ear structural anomalies (e.g., Mondini deformity, sinus hypoplasia in the related WS-spectrum case) - Echocardiography — recommended given the newly reported PDA/pulmonary hypertension association; the 2024 case authors explicitly argue for routine cardiac screening in CDHS given the neural-crest-cardiac link

Genetic testing: - First-line: PAX3 single-gene sequencing (all coding exons + flanking intron/exon boundaries) — the approach used in essentially every reported case - Deletion/duplication analysis (chromosomal microarray / CMA) — necessary given the 2014 case's whole-gene deletion mechanism; sequencing alone would have missed this - Whole-exome sequencing (WES) — used in the 2024 case (Illumina NextSeq, GRCh37 reference, GATK4.3 variant calling, ANNOVAR annotation), confirmed by Sanger sequencing; also useful to exclude phenocopies (e.g., the 2024 authors screened >100 congenital heart disease genes to rule out an alternative cardiac explanation) - NCBI GTR lists PAX3 as the associated gene with 141 available clinical tests (sequencing, deletion/duplication, targeted variant analysis)

Clinical criteria / differential diagnosis: Key differential is Waardenburg syndrome types 1 and 3 (also PAX3-caused) — CDHS is distinguished by its imaging findings (absent nasal bones, normal calvarium) and distinct facial gestalt, and notably by the absence of the classic WS pigmentary stigmata (white forelock, heterochromia iridis, synophrys/dystopia canthorum) in the founding description, although some overlap (e.g., an iris pigmentary lesion) has since been reported. Other differentials include other PAX3-spectrum/2q36.1 microdeletion phenotypes and other craniofacial-limb syndromes (e.g., Nager, Treacher Collins — distinguished by absence of hand ulnar-deviation pattern and different inheritance/gene).

Screening: No population screening program exists (ultra-rare disorder); universal newborn hearing screening (as recommended broadly for congenital deafness, including WS-spectrum disorders) would be the relevant entry point for early detection, given deafness is often the most immediately actionable finding.

11. Outcome / Prognosis

Survival/mortality: No mortality data specific to CDHS exist; life expectancy for the core triad (craniofacial + deafness + hand) appears normal absent complications. The one reported cardiovascular case illustrates that undiagnosed/untreated cardiac involvement can be life-threatening — by young adulthood the patient had developed severe, inoperable pulmonary hypertension from an unrepaired PDA, a course associated with significant morbidity/mortality risk if untreated in classic PDA natural history.

Morbidity/function: Profound deafness is the dominant lifelong functional impact (communication, speech-language development, education, social integration) if not addressed early with hearing aids/cochlear implantation and habilitation. Hand contractures may impair fine-motor function, though the degree of functional hand impairment is not quantified in available reports.

Complications: Cardiovascular complications (PDA, pulmonary hypertension, cardiomegaly, valvular insufficiency) — newly recognized, possibly underascertained in earlier cases because cardiac screening was not systematically performed; kyphoscoliosis/thoracic deformity; undernutrition (secondary, one case).

Prognostic factors: Timeliness of diagnosis and multidisciplinary care appears to be the dominant modifiable prognostic factor illustrated by the literature — the 2024 case authors explicitly frame their patient's poor cardiovascular outcome as a consequence of fragmented, non-holistic care and delayed genetics referral (14+ years from murmur detection to genetic diagnosis), not an inevitable disease course.

12. Treatment

There is no disease-modifying or curative therapy for CDHS — management is entirely supportive/symptomatic, directed at each phenotypic domain.

Hearing loss management: - Hearing aids / cochlear implantation (standard of care for congenital severe-profound SNHL; not explicitly documented as performed in the reported CDHS cases, but standard practice for the WS/PAX3-spectrum) - Speech-language therapy - NCIT suggestion: NCIT:C15315 (Rehabilitation), NCIT:C159273 (Speech Therapy) — verify against your NCIT adapter

Hand anomaly management: - Occupational/physical therapy for contractures; surgical release considered case-by-case (not specifically documented in reported CDHS cases) - NCIT: NCIT:C15302 (Physical Therapy), NCIT:C121351 (Occupational Therapy)

Cardiovascular management (2024 case, symptomatic/palliative given inoperability from established pulmonary hypertension): - Furosemide (loop diuretic) — CHEBI: furosemide, CHEBI:47426 - Bosentan (dual endothelin-receptor antagonist) — CHEBI:3181 (verify) - Enalapril (ACE inhibitor) — CHEBI:4784 (verify) - Sildenafil (phosphodiesterase-5 inhibitor) — CHEBI:9139 (verify) - Treatment term: NCIT:C15986 (Pharmacotherapy) for all four; therapeutic_agent bound to the respective CHEBI terms - The authors explicitly frame this regimen as not curative — "aim to manage symptoms rather than provide curative treatment" — because surgical PDA closure was contraindicated by the degree of established pulmonary hypertension (irreversible Eisenmenger-type physiology)

Surgical: PDA closure would be first-line if performed early (standard congenital cardiology practice), but was deemed unsuitable in the one reported CDHS case due to delayed diagnosis and established severe pulmonary hypertension — an argument for early echocardiographic screening in future CDHS diagnoses.

Genetic counseling: Recommended given autosomal dominant inheritance with a 50% transmission risk to offspring of an affected individual; molecular confirmation in a family enables predictive testing of at-risk relatives (extrapolated from general PAX3/WS management guidance, e.g., GeneReviews' Waardenburg Syndrome Type I chapter, PMID/NBK1531).

Experimental / clinical trials: None identified — no ClinicalTrials.gov entries specific to CDHS were located; the extreme rarity precludes trial-based development.

Treatment strategy / personalized medicine: The clearest actionable lesson from the literature is procedural rather than pharmacological: early, coordinated multidisciplinary evaluation (genetics, audiology, cardiology, orthopedics) at diagnosis, rather than isolated single-specialty management — explicitly the central argument of the most recent (2024) case report.

13. Prevention

  • Primary prevention: Not applicable — CDHS arises from de novo or inherited single-gene mutation; there is no known modifiable risk factor to prevent occurrence.
  • Secondary prevention: Early recognition of the craniofacial-hand phenotype should prompt (a) immediate audiologic evaluation/newborn hearing screening and (b) — based on the 2024 case's central lesson — routine echocardiographic screening, given the emerging cardiac neural-crest association, even though this is based on a single case to date.
  • Genetic counseling / reproductive options: Standard autosomal dominant counseling (50% recurrence risk per pregnancy for an affected parent); prenatal or preimplantation genetic testing would be technically feasible once a familial PAX3 variant is identified, though not documented as having been used in any reported CDHS family.
  • Screening programs: No CDHS-specific screening program exists; universal newborn hearing screening (a general public-health measure, not CDHS-specific) is the most relevant existing infrastructure that would flag an affected infant.

14. Other Species / Natural Disease

No naturally occurring CDHS-equivalent disease has been reported in any non-human species. PAX3 orthologs are highly conserved (mouse Pax3, and Pax3 orthologs across vertebrates), and Waardenburg-like pigmentary/deafness phenotypes are well documented in animals with PAX3-pathway disruption (e.g., naturally occurring white-spotting/deafness phenotypes in some mammals are linked to MITF-pathway genes, of which PAX3 is an upstream regulator), but no natural veterinary case has been specifically characterized as a CDHS analog (i.e., with the combined craniofacial + deafness + hand/limb triad). This is an evidence gap, not a documented negative finding — it likely reflects the extreme rarity and specificity of the human phenotype rather than true absence of comparable biology in other species.

15. Model Organisms

Mouse — Splotch (Sp) mutant, Pax3 loss-of-function: - Classic neural tube defect model: exencephaly and spina bifida from failure of dorsal neural tube closure, with severity increasing along the rostrocaudal axis (PMID:8421686 and related Pax3/vertebrate development literature) - Splotch mice additionally show cardiac neural crest phenotypes — myocardial dysfunction, persistent truncus arteriosus, and cardiac outflow-tract malalignment — cited by the 2024 CDHS case-report authors as the mechanistic precedent for their patient's PDA/pulmonary hypertension - Important human-model mismatch: Splotch mice reportedly have no facial phenotype, whereas human PAX3 loss-of-function clearly causes craniofacial dysmorphism (WS1/WS3/CDHS) — indicating the facial neural-crest role of Pax3 is not fully recapitulated in this mouse model, and caution is warranted before extrapolating mouse craniofacial findings (or their absence) to human CDHS. - Persistent Pax3 expression (gain-of-function) in neural crest causes cleft palate and defective osteogenesis in mice (JCI, PMID referenced above) — relevant to understanding dosage sensitivity of PAX3 in craniofacial development, though this is the opposite direction of the presumed CDHS mechanism.

Mouse — cochlear melanocyte studies: Pax3 loss reduces melanocytes in the developing mouse cochlea (Scientific Reports, 2024), supporting a melanocyte-dependent mechanism for the sensorineural hearing loss common to PAX3-spectrum disorders including CDHS.

Zebrafish/medaka: Pax3 and Pax7 function combinatorially with Mitf to generate melanophores/xanthophores (bioRxiv 2023) — general PAX3-pathway biology, not CDHS-specific.

Applications/limitations: No mouse or other model has been engineered to carry the specific CDHS-associated paired-domain alleles (N47K, T31P) or has recapitulated the full human CDHS triad (craniofacial + deafness + hand). All model-organism evidence cited in CDHS discussions is extrapolated from general Pax3 loss-of-function biology, not validated against the specific human CDHS variants — this represents a genuine translational/model-fidelity gap worth flagging explicitly (a HUMAN_MODEL_MISMATCH-type gap, in dismech schema terms) rather than treating mouse Pax3 data as direct confirmation of CDHS mechanism.

Summary of Key Evidence Gaps

  1. No MONDO ID confirmed in this session — needs direct OAK/MONDO lookup.
  2. No dedicated GeneReviews chapter for CDHS exists (only for Waardenburg Syndrome Type I) — CDHS content must be synthesized from OMIM/Orphanet/primary case reports, as done here.
  3. Extremely small evidence base (≈4–5 total published cases/families across >40 years) — essentially every quantitative claim (prevalence, penetrance, sex ratio) is a qualitative impression from a handful of individuals, not a population statistic.
  4. Cardiovascular association is single-case evidence (PMID:39850491) — real but not yet independently replicated; should be curated as an emerging/tentative association, not an established core phenotype.
  5. No confirmed CDHS-specific animal model — all mechanistic model-organism support is inferential from general Pax3 biology, with an explicit facial-phenotype mismatch between mouse (Splotch, no facial phenotype) and human (craniofacial-dominant phenotype) PAX3 loss-of-function.

Primary Citations (PMID)

  • 6859126 — Sommer, 1983, original description
  • 8664898 — Asher et al., 1996, N47K PAX3 missense mutation
  • 14556253 — Sommer et al., 2003, 20-year follow-up ("revisited")
  • 18553554 — Gad et al./PMC2533638, 2008, WS-spectrum case, no PAX3 mutation found
  • 24839464 — Drozniewska et al., 2014, 862 kb 2q36.1 deletion case
  • 39850491 — Saenz Hinojosa et al., 2024/2025, PAX3 T31P + PDA/pulmonary hypertension case
  • 8421686 — Splotch mouse Pax3 intron-3 splicing mutation

Sources: - OMIM #122880 — CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS - OMIM *606597 — PAX3 - Orphanet: Craniofacial-deafness-hand syndrome (ORPHA:1529) - PubMed 8664898 — Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome - PubMed 14556253 — Craniofacial-deafness-hand syndrome revisited - PubMed 6859126 — Previously undescribed syndrome of craniofacial, hand anomalies, and sensorineural deafness - PMC11754966 / Frontiers in Genetics — Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms - PMC2533638 — Sensorineural Deafness, Distinctive Facial Features and Abnormal Cranial Bones: a New Variant of Waardenburg Syndrome? - PMC4023700 — PAX3 gene deletion detected by microarray analysis in a girl with hearing loss - PAX3: A Driver of Normal Development and Disease (PMC13024339) - NCBI GTR — Craniofacial-deafness-hand syndrome (C1852510) - GARD/NIH — Craniofacial-deafness-hand syndrome - NORD — craniofacial-deafness-hand syndrome - Waardenburg Syndrome Type I — GeneReviews (NBK1531) - Cellular mechanisms underlying Pax3-related neural tube defects and their prevention by folic acid (PMC6899032) - Loss of Pax3 causes reduction of melanocytes in the developing mouse cochlea (Scientific Reports)

OpenScientist ▸
Craniofacial-Deafness-Hand Syndrome (CDHS): Comprehensive Disease Characteristics Report
openscientist-autonomous 16 citations 2026-08-01T00:23:33.803111

Craniofacial-Deafness-Hand Syndrome (CDHS): Comprehensive Disease Characteristics Report

Disease: Craniofacial-Deafness-Hand Syndrome (CDHS) MONDO ID: MONDO:0007395 OMIM: #122880 | Orphanet: ORPHA:1529 | Category: Mendelian (autosomal dominant neurocristopathy) Causal gene: PAX3 (2q36.1)

Summary

Craniofacial-Deafness-Hand Syndrome (CDHS; OMIM #122880; MONDO:0007395) is an extremely rare autosomal dominant congenital malformation syndrome caused by heterozygous missense mutations in the paired domain of the PAX3 gene on chromosome 2q36.1. The disorder is defined by a characteristic triad: (1) craniofacial dysmorphism — absent or hypoplastic nasal bones, a small short nose with slit-like nares, hypertelorism, and short (blepharophimotic) palpebral fissures; (2) profound congenital sensorineural deafness; and (3) hand anomalies — ulnar deviation of the fingers, flexion contractures of digits 3–5, and limited wrist movement with hypoplastic wrist bones. The prototypical mutation is p.Asn47Lys (N47K) at codon 47 of the PAX3 paired domain, first identified by Asher and colleagues in 1996 [PMID: 8664898].

CDHS belongs to the PAX3 allelic disorder spectrum, which also includes Waardenburg syndrome types 1 and 3 (WS1, WS3). Notably, the allelic mutation p.Asn47His (N47H) at the identical codon causes Waardenburg syndrome type 3, demonstrating that different amino-acid substitutions at a single conserved residue produce distinct phenotypes. Unlike Waardenburg syndrome, CDHS characteristically lacks the pigmentary anomalies (heterochromia iridis, white forelock) and dystopia canthorum that define the Waardenburg phenotype, while uniquely featuring absent/hypoplastic nasal and wrist bones with digital contractures.

Mechanistically, CDHS is a neurocristopathy: PAX3 is a master transcription factor governing the development, survival, migration, and differentiation of neural-crest derivatives and myogenic progenitors. Codon-47 paired-domain mutations disrupt PAX3 DNA binding and subnuclear dynamics, impairing the development of neural-crest-derived structures — including the melanocytes of the cochlear stria vascularis (explaining the sensorineural deafness), the craniofacial skeleton and mesenchyme, and, as reported in a 2024 case, cardiac outflow-tract derivatives. The murine Splotch (Pax3 mutant) provides the disease model, recapitulating neural-crest, inner-ear, and cardiac defects. Fewer than ~10 individuals with CDHS have been reported worldwide; management is entirely multidisciplinary and supportive (cochlear implantation, hand surgery and therapy, genetic counseling), with no cure or disease-modifying therapy.

Key Findings

Finding 1 — CDHS is caused by heterozygous PAX3 paired-domain missense mutations at codon 47

CDHS is an autosomal dominant disorder caused by heterozygous missense mutations affecting codon 47 of the PAX3 paired (DNA-binding) domain. In the original molecular characterization, Asher et al. (1996) studied a three-member family — a mother and two affected children — and identified a p.Asn47Lys (N47K) substitution. As stated in the abstract: "In a family of three affected individuals with this syndrome, a mother and two children, a missense mutation (Asn47Lys) in the paired domain of PAX3 was initially detected by SSCP analysis" [PMID: 8664898].

Critically, this substitution appears to have a more profound functional consequence than typical loss-of-function alleles: "Substitution of a basic amino acid for asparagine at residue 47, conserved in all known murine Pax and human PAX genes, appears to have a more drastic effect on the phenotype than missense, frameshift and deletion mutations of PAX3 that cause Waardenburg syndrome type 1" [PMID: 8664898]. This suggests the N47K allele is not a simple haploinsufficiency but may alter PAX3 function in a manner beyond dosage reduction.

The causal mutation was independently confirmed in a 20-year longitudinal follow-up of the same phenotype by Sommer & Bartholomew (2003): "A missense mutation in the paired domain of PAX3 (Asn47Lys) was detected" [PMID: 14556253]. A more recent 2024 case confirmed a pathogenic PAX3 missense variant by whole-exome sequencing [PMID: 39850491], corroborating the genetic basis across nearly three decades of reporting.

Ontology/annotation: Gene PAX3 — HGNC:8617, NCBI Gene 5077, UniProt P23760, OMIM *606597, locus 2q36.1. Variant nomenclature: PAX3 p.Asn47Lys (N47K); allelic WS3 variant p.Asn47His (N47H).

Finding 2 — The clinical phenotype is a triad of craniofacial dysmorphism, profound sensorineural deafness, and hand anomalies

Asher et al. (1996) define CDHS by "the absence or hypoplasia of the nasal bones, profound sensorineural deafness, a small and short nose with slitlike nares, hypertelorism, short palpebral fissures, and limited movement at the wrist and ulnar deviations of the fingers" [PMID: 8664898]. The long-term follow-up study added further craniofacial and limb detail: "a depressed nasal bridge with a button tip and slitlike nares and a small 'pursed' mouth. Profound sensorineural hearing loss and ulnar deviation of the hands with flexion contractures of digits three, four and five" [PMID: 14556253], along with a flat facial profile and an antimongoloid (downslanting) slant of the palpebral fissures.

The original description was in a mother and two children across two generations, consistent with autosomal dominant inheritance. The phenotype is congenital and appears to be relatively stable rather than progressive (see Temporal Development, below).

Finding 3 — PAX3 is a neural-crest/myogenic transcription factor; codon-47 mutations disrupt DNA binding and subnuclear dynamics

PAX3 encodes a transcription factor with an N-terminal DNA-binding region (a paired box plus a homeodomain) and a C-terminal transactivation domain. It is "expressed during development of skeletal muscle, central nervous system and neural crest derivatives, and regulates expression of target genes that impact on proliferation, survival, differentiation and motility in these lineages" [PMID: 29730428]. This developmental role in neural-crest lineages directly underlies the multi-system CDHS phenotype.

PAX transcription factors are essential for neural-crest induction and the formation of derivatives including "the craniofacial skeleton and mesenchyme, the heart outflow tract, endocrine and pigment cells" [PMID: 26410165] — precisely the structures affected in CDHS (craniofacial bones, and, in a recent case, cardiac outflow-tract anomalies).

Codon 47 lies within the paired domain. Corry et al. (2010) demonstrated that the PAX3 paired domain and homeodomain function interdependently as a single DNA-binding module and that "disease-causing missense mutations in PAX3 has established the interdependence of its two DNA-binding domains, the paired domain (PD) and the homeodomain (HD), as well as defects in localization and mobility" [PMID: 20643146]. This provides the mechanistic basis for how a single-residue substitution at codon 47 impairs PAX3's ability to bind DNA and regulate its target-gene network with proper subnuclear localization and mobility.

An additional, transcription-independent PAX3 function is relevant: Pax3 stabilizes neural-tube and neural-crest development by promoting Mdm2-mediated ubiquitination and degradation of p53, using its paired domain and homeodomain independent of DNA binding [PMID: 22216266]. Loss of this p53-suppressing activity in Splotch Pax3 mutants underlies neural-tube and cardiac neural-crest defects.

Ontology suggestions — GO biological processes: neural crest cell migration (GO:0001755), neural crest cell differentiation (GO:0014033), regulation of transcription by RNA polymerase II (GO:0006357), skeletal muscle tissue development (GO:0007519). GO cellular component: nucleus (GO:0005634), transcription regulator complex (GO:0005667). Cell types (CL): neural crest cell (CL:0000333), melanocyte (CL:0000148).

Finding 4 — The Splotch (Pax3 mutant) mouse is the disease model, recapitulating neural-crest, inner-ear, and cardiac defects

The murine Splotch allele series carries Pax3 mutations and provides the canonical model organism for PAX3 disorders. Splotch mice "develop neural tube defects (NTDs), comprising exencephaly and/or spina bifida, as well as neural crest-related defects and abnormalities of limb musculature" [PMID: 19180568].

Most directly relevant to the CDHS deafness phenotype, Kim et al. (2014) showed that Pax3 is required for inner-ear structures with melanogenic fates: "In the absence of Pax3 in Pax3(Cre/Cre); R26R inner ears, β-gal-positive cells disappeared from regions with melanocytes such as the stria vascularis of the cochlea and dark cells in the vestibule" [PMID: 24565836]. Pax3-lineage melanogenic cells migrate to the inner ear but fail to differentiate and survive without Pax3 — providing the cellular mechanism linking PAX3 dysfunction to sensorineural deafness (the stria vascularis is essential for generating the endocochlear potential).

For the cardiovascular associations, Chan et al. (2004) demonstrated that homozygous Sp2H embryos "show delayed onset of cardiac neural crest emigration" with significantly reduced neural-crest cell numbers along the cardiac outflow migratory pathway [PMID: 15226254]. Mansouri et al. (2001) established that Pax3 acts cell-autonomously in the neural tube and somites by controlling cell-surface properties [PMID: 11493522].

Ontology/annotation: NCBI Taxon Mus musculus (10090); ortholog Pax3 (NCBI Gene 18505). Splotch also serves as the model for folic-acid-preventable neural tube defects.

Finding 5 — CDHS is extremely rare (<10 reported individuals); diagnosis is molecular; a 2024 case links it to cardiovascular anomalies

CDHS is described as "an extremely rare autosomal dominant condition" [PMID: 39850491]. Only a handful of individuals have been reported since the original 1983 clinical description:

Report Year PMID Contribution
Asher et al. 1996 8664898 Family of 3; identified N47K mutation
Sommer & Bartholomew 2003 14556253 20-year follow-up; confirmed N47K
Gad et al. 2008 18553554 Possible variant case; no PAX3 change found — suggests heterogeneity
Drozniewska & Haus 2014 24839464 ~862 kb 2q36.1 deletion including PAX3; overlapping features
Saenz Hinojosa et al. 2024 39850491 Novel PAX3 missense; cardiovascular anomalies

Diagnosis is confirmed by molecular genetic testing. The 2024 case used whole-exome sequencing (Illumina NextSeq) to identify a novel pathogenic PAX3 missense variant in "a 21-year-old Ecuadorian male with facial and hand dysmorphias, cardiomegaly, pulmonary hypertension, and patent ductus arteriosus (PDA)" [PMID: 39850491], newly expanding the CDHS phenotype to include cardiovascular involvement — biologically plausible given PAX3's role in cardiac neural crest. In an overlapping-phenotype patient, chromosomal microarray detected a "~862 kb de novo deletion at 2q36.1 including PAX3" [PMID: 24839464], demonstrating CMA as an alternative diagnostic modality. No population prevalence or incidence figures exist given the extreme rarity, and there is no established newborn screening.

Finding 6 — CDHS sits within the PAX3 allelic disorder spectrum; differential diagnosis centers on Waardenburg syndromes

PAX3 mutations produce a spectrum of allelic auditory/neurocristopathy disorders: Waardenburg syndrome type 1 (WS1; heterozygous loss-of-function; auditory-pigmentary with dystopia canthorum), Waardenburg syndrome type 3 / Klein-Waardenburg (WS3; extreme WS1 with musculoskeletal/upper-limb defects), and CDHS. Wollnik et al. (2003) noted that "Klein-Waardenburg syndrome (WS-III) is a very rare condition and represents an extreme presentation of WS-I, additionally associated with musculoskeletal abnormalities" and demonstrated that homozygous paired-domain missense variants can cause WS3 while heterozygous carriers show WS1 — establishing dosage/allele-specific severity within the paired box [PMID: 12949970].

The genotype-phenotype relationship at codon 47 is the sharpest illustration of allele-specific effects: "A previously described missense mutation in this same codon (Asn47His) is associated with Waardenburg syndrome type 3 (Hoth et al., 1993)" [PMID: 8664898]. Thus N47K → CDHS and N47H → WS3 at the identical conserved residue. CDHS is distinguished from Waardenburg by uniquely featuring absent/hypoplastic nasal and wrist bones and characteristic hand contractures, without the pigmentary anomalies (heterochromia, white forelock) or dystopia canthorum that typify Waardenburg. Gad et al. (2008) reported a patient sharing some but not all features, in whom no PAX3 sequence alteration was found, and concluded there may be genetic heterogeneity even within the CDHS subtype [PMID: 18553554].

Finding 7 — Verified ontology and database identifiers

Cross-references retrieved from the MONDO term MONDO:0007395 via EBI OLS4:

Resource Identifier
MONDO MONDO:0007395
OMIM 122880
Orphanet ORPHA:1529
Disease Ontology DOID:0111336
GARD 0001571
ICD-9 759.89
ICD-11 (foundation) 1355682887
MeSH C536453
UMLS C1852510
MedGen 377694
SNOMED CT 702362004

Synonyms (MONDO): CDHS; "Sommer-Young-Wee-Frye syndrome"; "craniofacial deafness hand syndrome"; descriptive synonym "features of flat facial profile, hypertelorism, hypoplastic nose with slitlike nares, and a sensorineural hearing loss." Causal gene PAX3: HGNC:8617, NCBI Gene 5077, UniProt P23760, OMIM *606597, locus 2q36.1.

Finding 8 — Official HPO phenotype profile (28 annotations) with frequency qualifiers

The curated Human Phenotype Ontology disease annotation for CDHS (MONDO:0007395; via Monarch Initiative, 28 disease–phenotype associations) provides frequency-qualified phenotypes:

Very frequent:

Phenotype HPO term
Sensorineural hearing impairment HP:0000407
Hypertelorism HP:0000316
Downslanted palpebral fissures HP:0000494
Blepharophimosis HP:0000581
Hypoplasia of the maxilla HP:0000327
Short nose HP:0003196
Depressed nasal bridge HP:0005280
Narrow mouth HP:0000160
Flat face HP:0012368
Narrow face HP:0000275
Aplasia/Hypoplasia involving the nose HP:0009924
Lacrimal duct atresia HP:0000564
Abnormality of the wrist HP:0003019
Ulnar deviation of the wrist HP:0003049
Ulnar deviation of finger HP:0009465

Frequent: Camptodactyly of finger (HP:0100490).

Additional annotations: Telecanthus (HP:0000506), Malar flattening (HP:0000272), Narrow naris (HP:0009933), Ulnar deviation of the hand (HP:0009487).

Section-by-Section Report

1. Disease Information

CDHS is a congenital autosomal dominant malformation syndrome characterized by the triad of distinctive craniofacial features (absent/hypoplastic nasal bones, hypertelorism, short slit-like nares, blepharophimosis), profound congenital sensorineural deafness, and hand anomalies (ulnar deviation, flexion contractures of digits 3–5, hypoplastic wrist bones). Key identifiers are listed in Finding 7 (OMIM #122880, ORPHA:1529, MONDO:0007395, MeSH C536453, ICD-9 759.89, ICD-11 foundation 1355682887, SNOMED CT 702362004). Synonyms include CDHS and "Sommer-Young-Wee-Frye syndrome." Information is derived from aggregated disease-level resources (OMIM, Orphanet, MONDO, HPO) and a small number of individual case reports — the entire literature comprises fewer than ~10 patients.

2. Etiology

Causal factor: Genetic — heterozygous missense mutations in the PAX3 paired domain, prototypically p.Asn47Lys (N47K) [PMID: 8664898]. A ~862 kb 2q36.1 deletion encompassing PAX3 has produced an overlapping phenotype [PMID: 24839464]. Genetic risk factors: The causal PAX3 variant is the sole established genetic determinant; no modifier genes or susceptibility loci are defined for this ultra-rare disorder. Environmental risk factors / protective factors / gene-environment interactions: None are established for CDHS specifically. (In the related Splotch mouse model, folic acid prevents Pax3-associated neural tube defects [PMID: 19180568], but this is not documented as relevant to the human CDHS phenotype.) Given the dominant, highly penetrant Mendelian mechanism, environmental contribution is not applicable.

3. Phenotypes

Phenotypes are physical manifestations/clinical signs, all congenital in onset. The HPO frequency-qualified profile (Finding 8) provides the authoritative catalog. The core features — sensorineural hearing impairment (HP:0000407), hypertelorism (HP:0000316), nasal hypoplasia (HP:0009924), and wrist/finger ulnar deviation (HP:0003049, HP:0009465) — are annotated as "Very frequent." Severity is typically severe for the hearing loss (profound sensorineural deafness) and moderate-to-severe for the structural anomalies; progression appears stable rather than progressive. Quality-of-life impact is dominated by profound congenital deafness (affecting communication/language acquisition) and by hand contractures limiting manual dexterity; formal QoL instrument data (EQ-5D, SF-36) are not available for this rare disorder.

4. Genetic/Molecular Information

Causal gene: PAX3 (OMIM 606597; HGNC:8617; NCBI Gene 5077; 2q36.1). Variant: p.Asn47Lys (N47K), a missense substitution in the paired domain, classified pathogenic; allelic to WS3-causing N47H. Allele frequency: Absent from population databases (de novo/private familial variants; not in gnomAD as a common allele). Origin: Germline; inherited autosomal dominant within families and arising de novo in sporadic cases. Functional consequence: Disruption of DNA binding and subnuclear localization/mobility of the paired domain–homeodomain module [PMID: 20643146]; the N47K substitution appears more deleterious than typical WS1 loss-of-function alleles [PMID: 8664898], consistent with an altered-function/dominant effect rather than simple haploinsufficiency. Chromosomal abnormality: A ~862 kb de novo 2q36.1 deletion including PAX3 detected by microarray [PMID: 24839464]. Modifier genes / epigenetics:* Not established.

5. Environmental Information

Not applicable. CDHS is a monogenic Mendelian disorder with no documented environmental, lifestyle, or infectious contributions.

6. Mechanism / Pathophysiology

CDHS is a neurocristopathy. The causal chain is:

PAX3 paired-domain mutation (N47K, codon 47)
│
▼
Impaired DNA binding + altered subnuclear localization/mobility  [PMID:20643146]
│
▼
Dysregulated PAX3 transcriptional network + loss of p53 suppression  [PMID:22216266]
│
▼
Defective development/survival/migration of NEURAL CREST derivatives + myogenic progenitors  [PMID:29730428, 26410165]
│
├──► Cochlear stria vascularis melanocytes fail to differentiate/survive ──► loss of endocochlear potential ──► PROFOUND SENSORINEURAL DEAFNESS  [PMID:24565836]
│
├──► Craniofacial skeleton/mesenchyme maldevelopment ──► absent/hypoplastic nasal bones, hypertelorism, flat face  [PMID:26410165]
│
├──► Cardiac neural crest migration defect ──► outflow-tract anomalies (PDA, pulmonary hypertension)  [PMID:15226254, 39850491]
│
└──► Limb/somitic musculoskeletal patterning defect ──► ulnar deviation, digit contractures, hypoplastic wrist bones

Molecular pathways: PAX3 transcriptional regulation of neural-crest and myogenic gene networks (e.g., MET, MYF5, DCT). Cellular processes: neural crest cell migration (GO:0001755), differentiation (GO:0014033), survival (regulation of apoptosis). Protein dysfunction: loss/alteration of paired-domain DNA-binding function; altered nuclear mobility. Cell types (CL): neural crest cell (CL:0000333), melanocyte (CL:0000148). Upstream: the PAX3 mutation; downstream: tissue-specific malformations. No metabolomic, proteomic, or single-cell profiling exists for human CDHS.

7. Anatomical Structures Affected

Organ/system level: ear (inner ear/cochlea — UBERON:0001846/UBERON:0001844), craniofacial skeleton/skull and nasal bones (UBERON:0001684 nasal bone), face, hands/wrists (UBERON:0002398 manus; UBERON:0001445 wrist), and — per the 2024 case — the cardiovascular system (heart outflow tract, ductus arteriosus). Tissue/cell level: neural-crest-derived melanocytes of the cochlear stria vascularis (UBERON:0002240 stria vascularis), craniofacial mesenchyme, cartilage/bone. Subcellular: nucleus (GO:0005634). Lateralization: bilateral and largely symmetric.

8. Temporal Development

Onset: Congenital (present at birth); features are developmental in origin. Onset pattern: Chronic/static. Progression: The malformations and deafness are stable and non-progressive; there are no defined disease stages. Duration: Lifelong. Critical period: Embryonic neural-crest migration and organogenesis (the window during which PAX3 acts); no postnatal intervention window exists to alter the developmental malformations. The 20-year follow-up confirmed a stable phenotype over time [PMID: 14556253].

9. Inheritance and Population

Inheritance: Autosomal dominant [PMID: 8664898, 39850491]. Epidemiology: Extremely rare (<10 reported individuals); no prevalence/incidence figures available. Penetrance: Appears high/complete in reported families (mother and both children affected). Expressivity: Likely variable, and possible genetic heterogeneity within the CDHS phenotype has been proposed [PMID: 18553554]. Sex ratio: No sex predilection documented (reported cases include both sexes). Founder effects / consanguinity / carrier frequency: Not applicable — dominant, private/de novo mutations. Geographic distribution: No specific geographic clustering; reported cases from multiple populations including a 2024 Ecuadorian patient [PMID: 39850491].

10. Diagnostics

Molecular genetic testing is the diagnostic gold standard. Recommended approaches: single-gene PAX3 sequencing or whole-exome sequencing (WES) — WES identified the pathogenic PAX3 missense variant in the 2024 case [PMID: 39850491]; chromosomal microarray (CMA) detects PAX3-encompassing deletions [PMID: 24839464]. Clinical evaluation: Audiometry/ABR confirms profound sensorineural hearing loss; craniofacial and skeletal (hand/wrist) radiography documents absent/hypoplastic nasal and wrist bones; the 2024 case underscores the value of echocardiography given cardiovascular involvement. Differential diagnosis: Waardenburg syndrome types 1 and 3 / Klein-Waardenburg syndrome — distinguished by the presence of pigmentary anomalies and dystopia canthorum in Waardenburg versus the nasal/wrist bone hypoplasia and digit contractures without pigmentary features in CDHS [PMID: 8664898, 12949970]. Screening: No newborn or population screening exists; cascade genetic testing of at-risk relatives is appropriate once a familial variant is known.

11. Outcome / Prognosis

Survival/mortality: CDHS is not intrinsically life-limiting; life expectancy is generally normal, though the newly reported cardiovascular anomalies (cardiomegaly, pulmonary hypertension, PDA) could carry morbidity/mortality risk in some individuals [PMID: 39850491]. Morbidity/disability: Dominated by profound congenital deafness (communication, language, educational impact) and hand contractures (reduced manual function). Recovery: The structural malformations are permanent; hearing can be functionally rehabilitated (see Treatment). Prognostic factors: Severity of hand/facial anomalies and presence/absence of cardiac involvement. No molecular prognostic biomarkers are defined.

12. Treatment

There is no cure or disease-modifying therapy; management is entirely multidisciplinary and supportive:

  • Hearing (NCIT — cochlear implantation): Hearing amplification and cochlear implantation for profound sensorineural deafness; early intervention supports language development. Speech/language therapy.
  • Hand anomalies (NCIT — orthopedic surgery, occupational therapy): Orthopedic/hand surgery and occupational/physical therapy for ulnar deviation and digit contractures to improve function.
  • Craniofacial: Reconstructive/craniofacial surgery as indicated for nasal and facial anomalies.
  • Cardiovascular: Cardiology evaluation and management of PDA/pulmonary hypertension when present [PMID: 39850491].
  • Genetic counseling: For affected individuals and families regarding the 50% autosomal dominant recurrence risk.

No pharmacotherapy, gene therapy, RNA-based, or targeted therapies exist or are in trials for CDHS. The 2024 report also highlighted a lack of holistic, coordinated care as a gap in current management.

13. Prevention

No primary prevention exists for this de novo/dominantly inherited Mendelian disorder. Secondary prevention consists of early audiologic detection and intervention to mitigate the developmental impact of deafness. Genetic counseling and, for families with a known pathogenic PAX3 variant, options for prenatal diagnosis or preimplantation genetic testing constitute the principal preventive measures. No immunization, behavioral, or public-health interventions are applicable.

14. Other Species / Natural Disease

The murine ortholog Pax3 (NCBI Gene 18505; Mus musculus, NCBI Taxon 10090) underlies the naturally occurring/spontaneous Splotch mutant, historically important in developmental genetics [PMID: 19180568]. PAX3/Pax3 is highly evolutionarily conserved (residue 47 is "conserved in all known murine Pax and human PAX genes" [PMID: 8664898]), and the gene's neural-crest function is conserved across vertebrates including zebrafish and Xenopus [PMID: 21687713]. No naturally occurring CDHS-equivalent disease is documented in companion animals or wildlife; there is no zoonotic dimension.

15. Model Organisms

The mouse is the principal model. The Splotch Pax3 allelic series (Sp, Sp2H, Sp2G, Splotch-delayed) includes spontaneous and engineered (lacZ knock-in, Cre) alleles [PMID: 11493522, 24565836]. Phenotype recapitulation: Splotch reproduces neural-crest defects, inner-ear melanocyte loss (stria vascularis — modeling the deafness mechanism) [PMID: 24565836], cardiac neural-crest migration defects (modeling cardiovascular involvement) [PMID: 15226254], and limb-muscle abnormalities [PMID: 19180568]. Limitations: Homozygous Splotch mice die from severe neural tube defects (exencephaly/spina bifida) not seen in heterozygous human CDHS, and no mouse carries the specific human N47K allele — so the model captures PAX3 loss-of-function biology and the neural-crest mechanism rather than the precise CDHS genotype. Resources: MGI (Mouse Genome Informatics), IMSR.

Mechanistic Model / Interpretation

CDHS is best understood as a paired-domain-specific PAX3 neurocristopathy. A single conserved residue — asparagine 47 — sits at the heart of the genotype–phenotype logic of the entire PAX3 disorder spectrum:

PAX3 codon-47 allele Substitution Disorder Distinguishing features
N47H Asn→His Waardenburg syndrome type 3 Pigmentary anomalies, dystopia canthorum, limb defects
N47K Asn→Lys CDHS Nasal/wrist bone hypoplasia, digit contractures; no pigmentary anomalies

That two different substitutions at the same residue yield distinct syndromes indicates the phenotype is governed not merely by loss of PAX3 dosage but by the specific biochemical consequence of each substitution on the paired-domain–homeodomain DNA-binding module and its downstream target selection [PMID: 20643146, 8664898].

The unifying downstream mechanism is impaired development of neural-crest derivatives. PAX3 controls proliferation, survival, migration, and differentiation across these lineages [PMID: 29730428, 26410165]. The most mechanistically resolved link is the deafness: PAX3-dependent melanocytes populate the cochlear stria vascularis, and in the absence of Pax3 these cells vanish [PMID: 24565836]. Because strial melanocytes (intermediate cells) are required to generate the endocochlear potential that powers hair-cell transduction, their loss produces profound sensorineural deafness — a mechanism shared with the pigmentary-deafness of Waardenburg but manifesting here without overt skin/hair pigmentary signs. The craniofacial and (newly appreciated) cardiac features similarly map onto PAX3-dependent craniofacial mesenchyme and cardiac neural-crest populations [PMID: 26410165, 15226254], while the hand/wrist and muscle anomalies reflect PAX3's role in somitic/limb myogenic progenitors [PMID: 21143873].

Evidence Base

PMID Title (abbrev.) Role in this report
8664898 Missense mutation in the paired domain of PAX3 causes CDHS Primary genetic + phenotypic source (N47K; codon-47 N47H→WS3 distinction)
14556253 Craniofacial-deafness-hand syndrome revisited 20-year follow-up; confirms N47K, expands phenotype
39850491 CDHS with unusual cardiovascular symptoms 2024 WES-confirmed case; adds cardiovascular phenotype; rarity
24839464 PAX3 deletion detected by microarray CMA diagnosis; 2q36.1 deletion; overlapping phenotype
18553554 New variant of Waardenburg syndrome? Possible CDHS heterogeneity; differential diagnosis
12949970 Homozygous/heterozygous PAX3 → different WS Defines WS3; allele-dosage severity
20643146 PAX3 PD+HD single binding module Mechanism: how missense mutations impair DNA binding/mobility
29730428 Expression and function of PAX3 PAX3 role in neural crest/muscle lineages
26410165 PAX in neural crest development Links NC to craniofacial skeleton + heart outflow tract
24565836 Pax3 for inner ear melanogenic fates Cellular mechanism of deafness (strial melanocyte loss)
19180568 Splotch mouse / NTDs Disease model; neural-crest + limb phenotypes
15226254 Cardiac neural crest in splotch Cardiac NC migration defect (cardiovascular link)
22216266 Pax3 stimulates p53 degradation Transcription-independent PAX3 function
11493522 Pax3 acts cell autonomously Cell-autonomous role in neural tube/somites

All quoted snippets in the Key Findings section are verbatim from the cited abstracts and were validated during the investigation.

Limitations and Knowledge Gaps

  1. Ultra-rarity: Fewer than ~10 individuals have ever been reported, so nearly all clinical and genetic conclusions rest on isolated case reports and one multi-generational family. Frequency estimates, penetrance, expressivity, and prognosis are correspondingly uncertain.
  2. Genotype breadth: Only one recurrent mutation (N47K) is firmly established plus a deletion and one novel missense variant; the full spectrum of CDHS-causing PAX3 alleles is unknown. Possible genetic heterogeneity was raised by a PAX3-negative case [PMID: 18553554].
  3. No functional studies of N47K specifically: Mechanistic inference relies on general PAX3 biology and other paired-domain mutations; the precise molecular consequence of N47K (versus N47H) has not been directly characterized in cellular assays.
  4. Cardiovascular association is preliminary: Based on a single 2024 case [PMID: 39850491]; whether cardiac anomalies are a consistent CDHS feature requires confirmation.
  5. No model of the human allele: The Splotch mouse models PAX3 loss-of-function, not the CDHS N47K substitution, and homozygotes have a lethal NTD phenotype not seen in human heterozygotes.
  6. No omics/QoL data: No transcriptomic, proteomic, metabolomic, or formal quality-of-life data exist for CDHS.

Proposed Follow-up Experiments / Actions

  1. Functional characterization of N47K vs N47H: In vitro DNA-binding, transactivation, subnuclear-mobility (FRAP), and target-gene (ChIP-seq) assays comparing the CDHS N47K and WS3 N47H alleles to explain the divergent phenotypes at codon 47.
  2. Knock-in mouse model: Generate a Pax3 p.N47K knock-in mouse to test whether it recapitulates CDHS-specific craniofacial, hand, inner-ear, and cardiac features, avoiding the homozygous-lethal NTD confound.
  3. Systematic phenotyping including echocardiography: Prospectively evaluate all known/newly identified CDHS patients with cardiac imaging to determine whether cardiovascular anomalies are a core feature.
  4. International registry / GeneMatcher outreach: Aggregate cases to define penetrance, expressivity, natural history, and the mutational spectrum.
  5. Cochlear/inner-ear mechanism validation: Single-cell/lineage analysis of strial melanocytes in the N47K model to confirm the endocochlear-potential mechanism of deafness.
  6. Standardized multidisciplinary care pathway: Develop coordinated (audiology, hand surgery, craniofacial, cardiology, genetics) management guidance, directly addressing the "lack of holistic care" flagged in the 2024 report [PMID: 39850491].

Report compiled from a 5-iteration autonomous investigation; 8 findings confirmed across 23 reviewed papers. All primary claims are supported by verified PMID-linked abstract quotations.

Artifacts